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The studies described in this dissertation explore the replication 
of poliovirus RNA from two approaches. We have investigated the interac-
tions between viral RNA synthesis and the production and distribution of 
cytoplasmic membranes. The quantitative aspects of poliovirus multipli-
cation under the combined effects of a specific virus inhibitor, guanidine 
hydrochloride, and compounds which block that inhibition, have also been 
studied. 
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Summary 
Picornavirus multiplication is intimately associated with intra-
cellular membranes and affects their production and distribution within 
the cell. We have shown that the density distribution of cytoplasmic 
membranes separated by isopycnic centrifugation in discontinuous sucrose 
gradients is progressively altered after infection of HeLa cells with 
poliovirus. The most striking change is a very large increase in the 
smooth microsomal membranes with which viral RNA synthesis is associa-
ted. These membranes begin to increase between 2.5 and 3.5 hours after 
infection, and continue to proliferate late in the virus growth cycle, 
at a time when cellular protein and nucleic acid syntheses are much 
reduced. 
These smooth membranes differ from the membranes in the corres-
ponding fraction from uninfected cells in several ways. They have a 
higher phospholipid/protein ratio and the phospholipid composition is 
altered. We have confirmed that the viral RNA polymerase activity is 
firmly associated with the membranes in this fraction and that it may 
be localized in a complex with a sedimentation constant of 130 S after 
lysis of the membranes with deoxycholate. 
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We have utilized H-choline as a specific precursor of choline-
containing phospholipids, to study the synthesis of cytoplasmic mem-
3 
branes. We have confirmed that the incorporation of H-choline into 
cytoplasmic membranes is greatly stimulated by poliovirus infection. 
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When uninfected or infected cells are pulsed for 3 minutes with H-
choline, and then fractionated on discontinuous sucrose gradients, the 
highest activity is found in the rough microsomal membranes which form 
a thick pellicle in the lower third of the centrifuge tube. These 
membranes probably constitute the intracellular location for the syn-
thesis and incorporation of phospholipids into membranes. Uninfected 
3 
cells still show this distribution of H-choline after 30 minutes of 
V 
labeling, but in infected cells, a bimodal distribution is observed. 
The radioactivity is preferentially incorporated into the accumulating 
smooth microsomal membranes as well as into the pellicle of rough 
microsomal membranes. 
When infected and uninfected cells are pulse-labeled for 3 
minutes with tritiated glycerol, the infected cells incorporate 4-5 
times as much radioactivity as uninfected cells. About 80% of the 
label is incorporated into the rough endoplasmic reticulum. After a 
60-minute chase period, the distribution of radioactivity does not 
change significantly in uninfected cells. By contrast, in infected 
cells, much of the label shifts from the rough microsomes into the 
smooth membranes, particularly those with which viral RNA synthesis 
is associated. Thus, it appears that there is preferential synthesis 
in the rough endoplasmic reticulum of lipid destined to become part 
of the smooth membranes which accumulate throughout infection. 
Treatment of infected cells with 1.0 to 2.0 mM guanidine-HCl 
inhibits viral RNA synthesis, but does not measurably affect cellular 
metabolism. We have confirmed the observation that early guanidine 
treatment of cells infected with at least 50 PFU per cell of polio-
virus does not block the virus-induced stimulation of choline incor-
poration, although this stimulation is diminished. However, such 
guanidine-treated, infected cells do not produce the large quantities 
of smooth surfaced membranes which normally accumulate in infected 
cells. Indeed, the density distribution of membranes in guanidine-
treated, infected cells resembles closely that of uninfected cells. 
This suggests that poliovirus products may affect the control of 
cellular membrane synthesis in two separable ways: incorporation of 
precursors, and the conversion of rough to smooth-surfaced membranes. 
We have also studied the choline-mediated blocking of the 
inhibitory action of guanidine on poliovirus biosynthesis in three 
cell types. Poliovirus biosynthesis shows increasing sensitivity to 
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inhibition by guanidine in the different cells in the order: HeLa cells, 
LLC-MK„ cells, and primary rhesus monkey kidney cells. When viral repli-
cation is more strongly inhibited in a given cell type, a higher concen-
tration of choline is required to block the inhibition. Kinetic studies 
in all three cell types show that 10 mM choline rapidly reverses the 
inhibitory effects of 0.4 mM guanidine. After addition of choline, viral 
multiplication proceeds at a rate indistinguishable from that in control 
cells that have received neither guanidine nor choline. Choline does not 
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appear to enhance the rate of exit of C-guanidine from cells incubated 
in guanidine-free medium. 
A variety of amino acids and compounds structurally related to 
choline are also known to have the ability to block guanidine inhibition 
of poliovirus replication. Although choline and methionine act synergis-
tically in blocking the virus-inhibitory action of guanidine, choline and 
dimethylethanolamine are incapable of synergism. This suggests that 
guanidine antagonists may be grouped into several classes. 
Choline, dimethylethanolamine and methionine all suppress the 
growth-supporting activity of 0.4 mM guanidine on a guanidine-dependent 
strain of poliovirus type 1. 
Possible mechanisms by which choline and other guanidine antago-
nists might block the action of guanidine on poliovirus multiplication 
are considered, and the implications of the results of our studies for 
these mechanisms are discussed. 
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Abbreviations 
Most of the abbreviations used in this dissertation are those 
for which the Journal of Biological Chemistry requires no definition 
[J. Biol. Chem. 246, 1-8 (1971)]. The following have also been used: 
MW - molecular weight 
PE - phosphatidylethanolamine 
PFU - plaque forming units 
PI - phosphatidylinositol 
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Poliovirus is one of the picornaviruses, a group of animal 
viruses consisting of a single-stranded RNA genome surrounded by a 
protein coat. Other picornaviruses which are quite similar to polio-
virus in the biochemistry of the viral replication cycle are foot-and-
mouth disease virus, mengovirus, coxsackieviruses and some of the 
echoviruses. Occasionally results of studies with these viruses will 
be cited in discussion of poliovirus replication. 
The poliovirus genome has a molecular weight which has been 
reported as 2 x 10 daltons (Schaffer, 1962) or, more recently, as 
2.6 x 10 daltons (Granboulan and Girard, 1969). Its coat contains 
4 proteins (Maizel, 1963; Summers et al., 1965). The molecular weights 
of the virus capsid proteins, which vary somewhat with different types 
of poliovirus, are as follows: VP1, 32-35,000; VP2, 25-28,000; VP3, 
23-24,000; VP4, 4-6,000 (Jacobsen et al., 1970; Holland and Kiehn, 
1968; Maizel and Summers, 1968). The molecular weight of the infec-
tious virus particle is about 7 x 10 daltons. 
The Virus Cycle 
Early Events 
Poliovirus adsorbs to specific protein receptors on the surface 
of susceptible cells (Holland and McLaren, 1961). Adsorption of the 
virus to plasma membrane receptors results in labilization of the capsid 
to proteolytic enzymes (Holland, 1962a; Holland and Hoyer, 1962). It is 
followed by penetration of the virion into the cell and proteolytic 
digestion of the capsid protein. Mandel (1967) suggests that penetra-
tion is achieved by a process of cellular phagocytosis, and that the 
capsid protein is digested within the phagocytic vesicle. The viral RNA 
is then released into the cytoplasm, and this is where the events of 
virus replication occur. 
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Viral Protein Synthesis 
The viral genome acts as messenger RNA, utilizing cellular ribo-
somes and transfer RNA molecules in association with cellular membranes 
in the production of viral protein. Early in the infective cycle viral 
polyribosomes have an average sedimentation constant of 380 to 400 S; 
each polyribosome contains about 30 to 50 ribosomes (Penman et al., 1963; 
Rich et al., 1963; Scharff et al., 1963; Summers et al., 1965, 1967). 
The viral polyribosomes are significantly larger than the typical poly-
ribosomes of uninfected HeLa cells, which have an average sedimentation 
constant of 200 to 250 S (Penman et al., 1963; Scharff et al., 1963). 
Late in the infective cycle the size and activity of viral polyribosomes 
declines (Summers et al., 1967). 
Viral protein is most likely made in one long piece which is later 
cleaved several times in specific places to form the various viral capsid 
and noncapsid proteins (Summers et al., 1965; Summers and Maizel, 1968; 
Jacobsen and Baltimore, 1968b; Jacobsen et al., 1970). Jacobsen et al. 
(1970) have shown that these cleavages may be blocked by treating in-
fected cells with the amino acid analogs canavanine, p-fluor©phenylalanine 
and azetidine-2-carboxylic acid. When this is done, a polypeptide 
(NCVP 00) with a molecular weight greater than 200,000 daltons is produced. 
This could represent the translation product of the entire poliovirus 
genome. 
Viral RNA Synthesis 
Three classes of virus-specific RNA have been isolated from and 
identified in poliovirus-infected cells. Single-stranded RNA, which is 
the size of mature poliovirus RNA, has a sedimentation constant of 33 S 
(Granboulan and Girard, 1969). There is an 18 S ribonuclease-resistant, 
double-stranded RNA, called replicative form (Bishop and Koch, 1967). 
Finally, there is a structure which has been called the replicative 
intermediate (Erickson et al., 1964; Baltimore and Girard, 1966); it is 
a partially ribonuclease-resistant multistranded complex. As isolated 
from infected cells, it has characteristics of both double- and single-
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stranded RNA, but its double-strandedness may be an artifact of the 
isolation procedure. 
Viral RNA is replicated in a complex which includes the RNA-
dependent viral RNA polymerase and replicative intermediate RNA. This 
"replication complex", which has been discussed by Girard et al. (1967), 
operates in association with membranes in the infected cell (Caliguiri 
and Tamm, 1970b). RNA strands complementary to the virus RNA, which have 
been termed "minus strands" are formed first; these are then used for the 
synthesis of more RNA identical to the virus RNA, which is also called 
the "plus strand". It is not known whether these two processes, produc-
tion of minus and plus strands, are performed by a single enzyme or more 
than one. The plus strands may be utilized in any one of three ways: 
in the synthesis of more viral RNA; in viral protein synthesis; and in 
the formation of the mature virion. Ribosomes (Caliguiri and Tamm, 
1970b) and viral proteins (Caliguiri and Mosser, submitted for publica-
tion) probably bind to the nascent viral RNA, still attached to the 
membrane-associated replication complex. This provides an efficient 
mechanism for the initiation of viral protein synthesis or morphogenesis 
of virions. 
Assembly and Release of Mature Virions 
The process of morphogenesis involves a final cleavage of a viral 
precursor protein, called NCVP6 or VPO (MW: 40,000), into two of the viral 
capsid proteins, VP2 (MW: 25-28,000) and VP4 (MW: 4-6,000) (Jacobsen and 
Baltimore, 1968a). Infected cells contain many particles with the morpho-
logical appearance of empty poliovirus capsids. These empty capsids con-
tain VPO and two viral capsid proteins, VPl and VP3, but no viral RNA 
(Schwerdt, 1957; Maizel et al., 1967). This structure may associate with 
the viral RNA after its constituent proteins have assembled, or the whole 
structure may assemble in association with the nascent viral RNA strands. 
Mature virus accumulates intracellularly and is eventually released 
into the surrounding medium either by lysis of the whole cell (Lwoff et 
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al., 1955; Amako and Dales, 1967a) or by pinching off of cytoplasmic 
blebs which then lyse to release their contents (Levinthal et al., 1969). 
Effects of Poliovirus Infection on its Host Cell 
During the course of picornavirus infection, cellular metabolism 
is altered radically. This has been extensively documented in the 
literature. I will confine my discussion primarily to studies in which 
poliovirus was utilized. Although there are some quantitative differences 
observed when picornaviruses other than poliovirus are used, qualitatively 
the results are in good agreement. 
Inhibition of Cellular Biosynthetic Processes 
Between one and two hours after infection cellular protein synthe-
sis declines sharply (Zimmerman et al., 1963; Holland and Peterson, 1964; 
Penman and Summers, 1965). Willems and Penman (1966) have presented evi-
dence that the initial manifestation of this inhibition is a disaggrega-
tion of cellular polyribosomes. Inhibition of cellular DNA synthesis 
appears to be secondary to inhibition of cellular protein synthesis 
(Ensminger and Tamm, 1970). Cellular RNA synthesis is also inhibited 
soon after infection, although not always as much as protein synthesis 
(Baltimore and Franklin, 1962; Zimmerman et al., 1963; Holland and 
Peterson, 1964; Holland, 1964). This inhibition seems to be the result 
of the inactivation of the cellular DNA-dependent RNA polymerase, rather 
than a loss of template activity of host DNA (Baltimore and Franklin, 
1962; Holland, 1962b). The kinetics with which the cellular synthetic 
processes are inhibited have been shown to depend on the multiplicity of 
infecting virus (Penman and Summers, 1965) and on the cell type used 
(Bablanian et al., 1965a). 
Stimulation of Phospholipid Synthesis 
Concomitant with these inhibitory effects, poliovirus infection 
stimulates the production of cellular phospholipids. Miroff and co-
workers (1957) reported that by 4 hours after infection with poliovirus 
32 
the incorporation of PO, into phospholipids of HeLa cells was greatly 
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stimulated. These results were confirmed by Cornatzer and co-workers 
(1961), who showed that the specific activities of T> in various phos-
pholipids were increased after poliovirus infection. At 4 hours after 
infection, the greatest increases in specific activity were found in 
phosphatidylethanolamine and phosphatidylcholine. Penman (1965) studied 
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the time course of incorporation of H-choline into trichloroacetic acid-
precipitable structures, and found that enhanced incorporation could be 
demonstrated between 2.5 and 3 hours after infection. This enhancement 
was abolished by treatment of the cultures with puromycin at 2 hours 
after infection, but only slightly reduced if puromycin was not added 
until 3 hours after infection. Virus which had been irradiated with 
ultraviolet light prior to inoculation was unable to stimulate the in-
corporation of choline into acid-precipitable structures. Thus, an 
active viral genome and some protein synthesis are necessary for the 
stimulation of phospholipid synthesis. 
Morphological Alterations 
The infected cell also shows gross cytopathological effects which 
are visible with the light microscope. Early in the viral cycle, inclu-
sions are detectable in the nucleus. The nuclear chromatin condenses in 
clumps around the nuclear envelope. Later the nucleus becomes highly 
irregular in outline and shrunken; it is displaced to one side of the 
cell by 8 hours after infection (Reissig et al., 1956; Dunnebacke, 1956). 
Barski et al. (1955) noted a large pale-staining area in the center of 
the cytoplasm which appeared more granular and compact than the remainder 
of the cytoplasm. Other authors have commented on a juxtanuclear area 
which stained differently from the remainder of the cytoplasm also 
(Dunnebacke, 1956; Reissig et al., 1956). By 6 hours after infection, 
a large percentage of the cells have become vacuolated and have retracted 
their cytoplasmic processes from the glass or plastic surface on which 
they were growing. They round up, develop breaks in the plasma membrane, 
and eventually lyse (Reissig et al., 1956; Bablanian et al., 1965a). 
In electron microscopic studies these changes have been confirmed 
and extended. The nuclear margination of the chromatin is among the 
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first changes to be noted. The Golgi vesicles, which normally are seen 
as stacks of flattened cisternae, are no longer morphologically identi-
fiable (Jezequel et al., 1966) and are replaced by an extensive accumu-
lation of smooth surfaced cisternae. The cisternae first become notice-
able in the centrosphere region of the cell at 3 hours after infection, 
and proliferate rapidly until they completely fill the central portion 
of the cell, displacing and squashing the nucleus to one side (Dales et 
al., 1965). This phenomenon partially explains two of the morphological 
alterations noted in the light microscopic studies, the changes in 
nuclear size and shape and the large pale staining area noted by Barski 
et al. (1955), which is probably identical with the area occupied by 
these cisternae. 
Amako and Dales (1967b) performed autoradiography in cells which 
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had been labeled with H-choline before and after infection. In both 
cases many grains were located over the area of proliferating cisternae. 
Differential centrifugation to separate various cellular organelles re-
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vealed the greatest amount of H label per milligram of phospholipid was 
in the microsomal fractions of both infected and uninfected cells. All 
fractions of infected cells incorporated more radioactivity than the 
comparable fractions of uninfected cells, but the increase in radio-
activity was greatest in the microsomal fraction. 
Also prominent in electron micrographs of cells infected with 
poliovirus for 3 hours or more are regions of dense randomly oriented 
filamentous or granular material. These have been termed viroplasm by 
Dales et al. (1965), who assumed that they are centers of virus assembly. 
Virus progeny can be detected readily by electron microscopy by 5 hours 
after infection. It is difficult to identify virus particles at earlier 
times in infection when they are not in characteristic arrays or in great 
numbers, for the size of poliovirus particles is similar to that of ribo-
somes. Paracrystalline arrays of virus are commonly seen in the cytoplasm 
of infected cells by 5 hours after infection (Dales et al., 1965). 
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Release of Lysosomal Enzymes 
Many of the cytopathological changes produced by picornavirus 
infection have been attributed to the release of hydrolytic enzymes 
from cellular lysosomes (Salzman et al., 1959; Wolff and Bubel, 1964; 
Flanagan, 1966; Amako and Dales, 1967b; Blackman and Bubel, 1969). 
Release of hydrolases has been studied in several laboratories using 
poliovirus (Flanagan, 1966; Bartsch et al., 1969; Wolff and Bubel, 1964) 
and mengovirus (Hotham-Inglewski and Ludwig, 1966) and release of lyso~ 
somal enzymes into a nonparticulate form was first observed at times 
ranging from 3 hours to 9 hours after infection. This variation corre-
lates fairly well with differences in the viral growth kinetics observed 
in these studies, and is probably due to differences in virus and cell 
strains used and in experimental techniques. In all cases it is possi-
ble that some or even all of the release of the enzymes occurred during 
the cell fractionation rather than in cells jLn situ. Release of lyso-
somal enzymes probably reflects increased membrane fragility in picorna-
virus- in fee ted cells. 
Evidence for the Importance of Cellular 
Membranes in Poliovirus Replication 
Investigations in many laboratories have shown that the biosyn-
thetic processes of poliovirus replication are closely associated with 
cellular membranes. Poliovirus RNA polymerase activity is found in the 
microsomal fraction of infected cells (Baltimore et al., 1963; Tershak, 
1966; Girard, 1969). All polymerase preparations so far studied are 
crude enzyme-template complexes which do not respond to added RNA primers 
of viral or cellular origin. Under the best conditions, the JLn vitro 
product is largely single-stranded viral RNA (Baltimore, 1964; Girard, 
1969) , but solubilization of the enzyme complex from the membranes re-
sults in the loss of activity or the synthesis of a product in which the 
proportion of single-stranded to double-stranded product is somewhat 
altered (Arlinghaus and Polatnick, 1967, 1969; Ehrenfeld et al., 1970; 
Girard et al., 1967; Polatnick and Arlinghaus, 1967; Plagemann and Swim, 
1968). 
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Differential centrifugation of infected cells yields a cytoplas-
mic membrane-associated structure which has been shown to contain polio-
virus-specific polyribosomes, viral RNA polymerase activity and much of 
the newly synthesized viral RNA, protein and mature virus (Becker et al., 
1963; Penman et al., 1964). Because the electron micrographs of infected 
cells ruptured by several cycles of freezing and thawing showed virus 
particles enclosed in membranous cisternae (Home and Nagington, 1959) , 
Penman and co-workers (1964) proposed the term "virus synthesizing body" 
for the cytoplasmic structures they had isolated, and assumed that all 
of the events in virus replication were performed here. More recently, 
however, Caliguiri and Tamm (1969, 1970a,b) were able to separate from 
each other the cellular membranes with which viral RNA and protein syn-
thesis are associated. This was done by isopycnic centrifugation of 
cytoplasmic extracts in discontinuous sucrose gradients. Most of the 
viral RNA synthesis is associated with a band, containing smooth micro-
somes, which comes to equilibrium in the upper part of the gradient. 
The bulk of viral protein synthesis is found in a rough microsomal 
fraction, which sediments as a thick, coherent pellicle. 
We have used the same fractionation method to separate the mem-
branes of infected cells for the investigations described in Chapters 3 
and 4 of this dissertation. Since it provides a means of distinguishing 
the cellular membranes used for two different viral functions, RNA and 
protein synthesis, it provides an excellent technique for the study of the 
interrelationships between virus multiplication and cellular membranes. 
Guanidine Hydrochloride - A Specific Virus Inhibitor 
Action of Guanidine 
Guanidine hydrochloride prevents the multiplication of poliovirus 
and many other picornaviruses when used at a concentration that has no 
measurable effect on cellular metabolism or multiplication (Rightsel et 
al., 1961; Crowther and Melnick, 1961; Brown et al., 1966). Guanidine 
exerts its effect by inhibition of viral RNA synthesis (Eggers et al., 
1963; Holland, 1963; Caliguiri et al., 1965) while allowing viral protein 
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synthesis to continue relatively undiminished (Caliguiri and Tamm, 1968b; 
Jacobsen and Baltimore, 1968a). Cultures treated with guanidine shortly 
after infection synthesize relatively little viral protein, probably as 
a secondary effect of the inhibition of production of viral RNA, which 
acts as messenger. Results of studies by Caliguiri and Tamm (1968a,b) 
lead to the conclusion that the primary process inhibited by guanidine 
is the initiation of synthesis of viral RNA strands. 
Guanidine has been used as a tool to study viral functions by many 
investigators. We can interpret these studies in the light of recent 
understanding that its mode of action is the inhibition of ongoing viral 
RNA synthesis without concomitant inhibition of viral protein synthesis. 
It has been shown that treatment of infected cells with guanidine 
does not prevent the virus-mediated suppression of cellular protein and 
nucleic acid synthesis (Bablanian et al., 1965a; Penman and Summers, 
1965). This seems to be a multiplicity dependent phenomenon. Cells 
infected at a low multiplicity of 10 PFU/cell may continue to synthesize 
cellular protein and nucleic acid at nearly normal rates in the presence 
of guanidine (Holland, 1964; Penman and Summers, 1965). However, these 
biosynthetic processes are rapidly inhibited if the cells are infected 
with 1,000 to 10,000 PFU/cell regardless of the presence or absence of 
guanidine (Holland, 1964). Similarly, Penman (1965) showed that in cells 
treated with 1.0 mM guanidine, the virus-controlled stimulation of choline 
incorporation is multiplicity dependent. At input multiplicities of 100 
PFU/cell or greater, the stimulation of cellular membrane synthesis caused 
by poliovirus infection is only slightly reduced by guanidine treatment. 
In both of these cases the metabolic changes due to poliovirus infection 
may be controlled by proteins synthesized using the parental viral RNA as 
messenger. As mentioned earlier, studies, utilizing ultraviolet inacti-
vation of the input virus or complete inhibition of protein synthesis, 
have shown that some translation of the viral genome is required; the 
capsids of the input virus seem incapable of performing the function of 
altering the cell's metabolic processes. 
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In contrast to the lack of effect of guanidine on virus control of 
cellular metabolism at high multiplicities of infection, cells treated 
with guanidine at any time up to 2 hours after infection do not show the 
cytopathological changes caused by virus infection in untreated cells 
within the time span of a single cycle of virus multiplication (Bablanian 
et al., 1965b). These changes are delayed for many hours until a time 
when they might well reflect the continuing inhibition of cellular protein 
and nucleic acid synthesis (Holland, 1963; Bablanian et al., 1965a). 
If guanidine is added at 4 hours after infection, virus-induced 
cell damage is not prevented even though virus yield is greatly reduced 
(Bablanian et al., 1965b). Most likely the morphological changes are 
produced in response to the synthesis of virus proteins, but these pro-
teins do not accumulate in concentrations capable of damaging the cells 
under conditions of limited messenger RNA production in cultures treated 
with guanidine early in the viral cycle. 
Blocking of Guanidine Inhibition 
The action of guanidine may be completely reversed by the removal 
of guanidine from the culture medium (Crowther and Melnick, 1961; Eggers 
et al., 1965). In 1964, it was discovered that the action of guanidine 
can also be reversed by the addition of certain compounds that are compo-
nents of many culture media (Lwoff and Lwoff, 1964; Dinter and Bengtsson, 
1964). Guanidine blockers include amino acids, methylated and ethylated 
amino alcohols such as choline, and methylated amines (Loddo et al., 1966; 
Philipson et al., 1966). 
There is evidence that the amino acids which block the inhibitory 
effect of guanidine act synergistically with compounds such as choline 
and dimethylethanolamine (Philipson et al., 1966). Apparently, different 
amino acids do not act synergistically with each other (Dinter and 
Bengtsson, 1964). We have tested the activity of combinations of choline 
and methionine, and choline and dimethylethanolamine against guanidine 
inhibition. Our results are reported in Chapter 5. 
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It has been reported that the degree of blocking of guanidine 
action by a variety of compounds is strongly dependent on the host cell 
(Philipson et al., 1966). We initiated our studies of the blocking of 
guanidine inhibition in the hope that exploitation of such cellular 
differences would enable us to probe the mechanism of action of these 
compounds. Our results, discussed in Chapter 5, indicate that the major 
difference between various cell types is in the sensitivity of the virus 
biosynthetic processes to guanidine in each. 
Guanidine-dependent Mutants of Poliovirus 
Almost immediately after the inhibitory action of guanidine was 
recognized, it was discovered that poliovirus mutants that are resistant 
to guanidine may be isolated. In infected cultures that have been 
treated with moderate concentrations of guanidine (e.g., 0.3 mM), some 
virus is produced. Most of this virus is genetically resistant to 0.3 
mM guanidine and multiplies in its presence (Melnick et al., 1961). 
Continual passage of such mutant stocks in gradually increasing concen-
trations of guanidine produces stocks of virus resistant to higher con-
centrations of guanidine. If these stocks are cloned, it is discovered 
that some clones are guanidine-dependent. They will not multiply in the 
absence of guanidine. 
The property of drug dependence has proved to be entirely congruent 
to drug sensitivity. Thus, the processes involved in drug dependance and 
drug sensitivity begin early in the viral cycle and extend through the 
exponential increase phase (Eggers et al., 1963, 1965). Viral RNA syn-
thesis is blocked in guanidine-deprived cultures infected with guanidine-
dependent poliovirus or in guanidine-treated cultures infected with 
guanidine-sensitive poliovirus (Eggers et al., 1963; Caliguiri et al., 
1965). 
There is some disagreement in the literature as to the action of 
compounds such as choline and methionine on the multiplication of the 
guanidine-dependent strain of poliovirus. Both Lwoff and Lwoff (1965) 
and Loddo and co-workers (1966) found that the poliovirus-supporting 
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action of 0.2 mM to 0.4 mM guanidine could be blocked by guanidine 
antagonists. Philipson et al. (1966), using 1.0 mM guanidine and a 
series of guanidine antagonists, could not detect any effect on the 
multiplication of guanidine-dependent poliovirus type 1. However, even 
high concentrations of guanidine blockers would probably not inhibit 
the action of 1.0 mM guanidine measurably. We investigated the effect 
of several guanidine antagonists on the replication of guanidine-
dependent poliovirus type 1 in HeLa cells in the presence of 0.4 mM 
guanidine, as described in Chapter 5. 
We have carried out a detailed quantitative study of the kinetics 
of virus multiplication after choline-mediated blocking of the inhibi-
tory action of guanidine. The use of antiserum against the residual 
virus in the inoculum in such a kinetic study allowed us to determine 
accurately the speed and effectiveness of choline action. 
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2. MATERIALS AND METHODS 
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Chapter 2 
Materials and Methods 
Materials 
Viruses 
Poliovirus type 2 (P712-ch-2ab) was used for most of the experi-
ments described in this dissertation. It was plaque purified (Dulbecco 
and Vogt, 1954) three times before use in the experiments described and 
was subsequently passaged twice in HeLa cell monolayers and no more than 
three times in S~ HeLa cells. Virus was purified by isopycnic centrifu-
gation in CsCl twice before use. This virus strain is sensitive to 
guanidine. 
Guanidine-dependent poliovirus type 1 (Brunhilde), received from 
Dr. N. Ledinko, was passaged in HeLa cell monolayers in the presence of 
1.0 mM guanidine. 
Cells 
So HeLa cells were obtained from Dr. J. V. Maizel and were main-
tained in suspension in Eagle's spinner medium (Eagle, 1959), with 7% 
calf serum. They were used for the experiments described in Chapters 3 
and 4. HeLa cell monolayers obtained from Dr. B. Mandel were maintained 
in 32 oz prescription bottles in reinforced Eagle's medium (Bablanian et 
al., 1965a) supplemented with 10% calf serum. LLC-MK„ cells, a continu-
ous rhesus monkey kidney cell line, were obtained from the American Type 
Culture Collection Cell Repository and maintained in the same way as HeLa 
cell monolayers. Primary cultures of rhesus monkey kidney cells (MKC) 
were prepared as described by Eggers and Tamm (1961), and were used on 
the fifth day after seeding. 
All continuous cultures were periodically treated with 50 jig/ml 
of tylosin tartrate (Ralston Purina Company, St. Louis, Mo.) to control 
contamination by mycoplasma (Friend et al., 1966). 
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Chemicals 
All chemicals used in the preparation of media and buffers were 
commercially available, analytical grade products. 
Lipostabilized calf serum was obtained from Grand Island Biologi-
cals, Grand Island, N. Y. For plaque assays and growth of virus stocks, 
calf serum which was certified as non-inhibitory to poliovirus (Special 
calf serum, Microbiological Associates, Inc., Bethesda, Md.) was used. 
All calf serum was heated to 56 C for 30 minutes before use in culture 
media, to destroy complement. 
Ribonuclease-free sucrose, used for the sucrose gradients, was 
obtained from Schwarz Bioresearch, Inc., Orangeburg, N. Y. EDTA was 
purchased from Fisher Scientific Co., Fair Lawn, N. J. 
Recrystallized guanidine•HCl and actinomycin D were obtained 
through the courtesy of Dr. A. F. Wagner of Merck, Sharp and Dohme Re-
search Laboratories, Rahway, N. J. Choline and methionine were purchased 
from Mann Research Laboratories, New York, N. Y. Dimethylethanolamine 
was obtained from Nutritional Biochemicals Corporation, Cleveland, Ohio. 
Phosphoenolpyruvate and phosphoenolpyruvate kinase were obtained 
from Calbiochem, Los Angeles, Calif. ATP, GTP and CTP were purchased 
from P. L. Biochemicals, Inc., Milwaukee, Wis. 
Trypsin, 1 x crystallized, and bovine pancreatic deoxyribonuclease 
I, electrophoretically purified, were purchased from Worthington Bio-
chemicals, Freehold, N. J. 
3 
H-Choline (methyl labeled, specific activity 100 mCi/mmole or 
greater) was obtained from Amersham/Searle, Des Plains, 111., or from 
3 
New England Nuclear, Boston, Mass. Glycerol-2- H (380 mCi/mmole) and 
3 
uridine-5- H (20 Ci/mmole were obtained from Amersham/Searle, Des Plains, 
14 
111. C-Guanidine-HCl (40 mCi/mmole) was obtained from International 
3 
Chemical and Nuclear Corporation, City of Industry, Calif. (5- H)-
Uridine-5'-triphosphate (17.8 Ci/mmole) was purchased from Schwarz 
Bioresearch, Orangeburg, N. Y. 
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Methods 
•Media and Solutions 
All nutrient media contained 500,000 units of penicillin G, 100 
mg streptomycin, and 25,000 units of mycostatin per liter. They were 
sterilized by filtration. 
Eagle's spinner medium (Eagle, 1959) was used with 7% calf serum 
for maintenance of S~ HeLa cells and was used unsupplemented for all 
experiments with these cells. 
Reinforced Eagle's medium was prepared according to Bablanian 
et al. (1965a). Eagle's minimum essential medium (MEM) (Egale, 1959) 
was used for all experiments with cells in monolayer culture, except as 
otherwise stated. 
RSB is reticulocyte standard buffer, and was prepared according 
to Caliguiri and Tamm (1970a). 
Phosphate-buffered saline (PBS) was prepared as described by 
Dulbecco and Vogt (1954). PBS-deficient is identical except that it 
lacks CaCl2 and MgCl . 
Trypsin-versene solution, used in cell passages, is 0.25% trypsin 
in 0.05% versene (EDTA) solution. It was sterilized by filtration. 
Polymerase buffer consists of 0.1 M Tris, pH 7.4; 1.0 mM MgCl~; 
and 5 ug/ml DNase. 
Immune Sera 
Poliovirus types 1 and 2 antisera were prepared in this laboratory 
by hyperimmunization of rabbits. 
Maintenance of Cell Stocks 
Monolayers of cells in continuous culture were subcultured every 
2 or 3 days. Confluent monolayers in 32 oz prescription bottles were 
washed twice with 20 to 50 ml warm PBS-deficient. Warm trypsin-versene 
solution (4.5 ml) was pipetted onto the cells and they were incubated 
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at 37 C for 5 minutes. The bottles were then shaken to detach the cells 
and the cell suspension was pipetted into a conical centrifuge tube. The 
suspension was centrifuged at 900 rpm for 5 to 10 minutes in an IEC cen-
trifuge and the supernatent decanted. The pellet of cells was dispersed 
in fresh medium and dispensed into bottles or tissue culture dishes. 
Bottles were gassed with 5% C09 in air, tightly capped, and incubated at 
36 to 37 C. Tissue culture dishes were swirled to spread the cells and 
incubated in a warm, humidified atmosphere of 5% C0« in air. 
S„ HeLa cells were maintained at a concentration of 1 to 4 x 10 
cells/ml by addition of medium to suspension cultures. At least once a 
week they were sedimented by centrifugation and resuspended in fresh 
medium. 
Growth and Purification of Virus 
Sq HeLa cells in suspension were infected with approximately 
6 
10 PFU/cell of virus at a cell density of approximately 5 x 10 to 
7 
1 x 10 cells/ml. After one hour the cells were diluted to approximately 
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2 x 10 cells/ml with warm Eagle's spinner medium containing 2% special 
calf serum. Cell-associated virus was harvested at 6.5 hours after infec-
tion by centrifugation at 1500 rpm x 15 minutes in an IEC refrigerated 
centrifuge. The pellet was resuspended in a small volume of PBS and 
cells were disrupted by 3 cycles of freezing and thawing. Cell debris 
was then removed by centrifugation at 10,000 x g for 20 minutes. Virus 
was purified from the supernatant by two isopycnic centrifugations in 
45% w/v CsCl (Harshaw Chemical Co., Hastings-on-Hudson, N. Y.), and CsCl 
was removed from the final band by passage through a 0.9 x 30 cm column 
of G-25 Sephadex (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.). 
Plaque Assays 
Plaque assays were performed as described by Eggers and Tamm (1962) 
except that the final concentration of calf serum was 5%, and cultures 
were generally incubated only two days before being read. Plaques could 
be read easily without staining with neutral red. All plaque assays were 
performed using HeLa cell monolayers. 
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Infection of S3 HeLa Cells for Experiments 
HeLa cells were sedimented by centrifugation and washed once in 
200 ml cold (4 C) Eagle's spinner medium. They were then resuspended 
in cold Eagle's spinner medium and infected with 25-150 PFU/cell of 
poliovirus in PBS. Control cultures received an equal volume of PBS. 
Cultures were stirred at 37 C for one hour and then diluted to their 
final volume. For details see individual experiments. 
Cell Fractionation 
Cells were harvested by pouring over crushed frozen PBS and cen-
tifuging immediately at 1500 rpm for 7.5 minutes at 4 C. They were 
washed once with 30 ml cold PBS and recentrifuged. The pellets were 
resuspended in 6.5 ml cold RSB and maintained at the temperature of 
melting ice for 20 minutes. They were then disrupted with approximately 
7 strokes with a tight-fitting dounce homogenizer or until inspection 
under the phase microscope showed that almost all of the cells had been 
broken. Nuclei, unbroken cells and large cell debris were sedimented 
by centrifugation at 900 x g for 10 minutes at 4 C in an IEC refriger-
ated centrifuge. Five ml of the supernatant (cell extract) were mixed 
with 5 ml 60% w/w sucrose-RSB and layered into a discontinuous sucrose 
gradient (Caliguiri and Tamm, 1970a) which was modified from that of 
Bosnian et al. (1968). This gradient is illustrated in Figure 1, p. 26. 
Gradients were centrifuged at 86,000 x g (Rav) for about 17 hours in a 
Spinco SW27 rotor. In our estimation, equilibrium was probably reached 
before this time. 
After centrifugation fractions were collected into 5/8" diameter 
x 3" cellulose nitrate tubes by means of Pasteur pipettes. The volume 
was brought up to 11.0 ml with cold RSB and the tubes were centrifuged 
at 95,000 x g for 2 hours in a Spinco type 40 rotor. The supernatants 
were decanted and pellets were resuspended in RSB using a Teflon pestle. 
Typically, 1.0 ml RSB was used for resuspension and the preparation was 
analyzed as follows: 0.2 ml was analyzed for protein; 0.2 ml was pre-
cipitated with trichloroacetic acid and radioactivity determined; and 
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lipids were extracted from 0.5 ml and used for phosphorus and radioactiv-
ity determinations. Approximately 40% of the total protein of the cyto-
plasmic extract and 95% or greater of the lipid phosphorus or lipid-
associated radioactivity were recovered in the pelleted fractions. 
Experiments on Blocking of Guanidine Action 
All experiments were performed in confluent monolayers in 60 mm 
plastic tissue culture dishes. Reinforced Eagle's medium was removed 
and cultures were washed once with warm PBS and inoculated with 0.5 ml 
of poliovirus diluted in PBS to give a multiplicity of 30-180 PFU/cell. 
After an adsorption period of one half hour at 37 C the cultures were 
washed once with warm PBS and treated with 0.5 ml of rabbit antiserum 
against the poliovirus type used. The antiserum was diluted so that it 
would reduce the background of input virus to 0.01% of the inoculum, or 
about 0.01 PFU/cell. The cultures were then incubated for an additional 
half hour, washed twice with warm PBS and 1.4 to 1.8 ml of MEM was added 
to give a final volume of 2.0 ml in each plate after the additions. 
Additions of guanidine and guanidine antagonists in PBS or MEM were made 
in 0.2 ml volumes. All cultures were incubated at 37 C in an atmosphere 
of 5% C0« in air until harvested. All experiments on the kinetics of 
virus multiplication were carried out in a 37 C constant temperature room. 
Samples were harvested by scraping cells from the plates and col-
lecting culture fluid and cells. Duplicate cultures were pooled and cells 
frozen immediately in an alcohol-dry ice bath. Subsequently, they were 
thawed and frozen twice more and stored at -20 C until assayed. Before 
assaying, the suspensions were thawed and centrifuged at 2000 rpm for 20 
minutes in an IEC refrigerated centrifuge to remove cell debris. 
Lipid Extraction 
Lipid extraction was performed as described by Folch et al. (1957). 
The surface of the non-aqueous phase was washed with chloroform:methanol: 
0.03 M MgCl2 in water, in the proportions 3:48:47 by volume. Samples 
were dried by heating to 56 C in a water bath overnight. 
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Phosphorus Determination 
Lipid phosphorus was determined by the method of Rouser et al. 
(1966) except that samples were digested in an oven at 150-160 C for 
3 hours rather than in a Kjeldahl rack, and all volumes were reduced by 
50%. Diphenylphosphate (Sigma Chemical Corporation, St. Louis, Mo.) 
was digested in the same manner as the samples and was used as a 
standard. Phospholipid content was occasionally calculated from the 
phosphorus content by assuming 770 as the average molecular weight of 
the phospholipids. 
Phospholipid Analysis 
Aqueous samples were sonicated in a Branson sonifier and protein 
contents were determined. The chilled sonicates were then precipitated 
by the addition of one half volume of 30% cold trichloroacetic acid. 
After 30 minutes in an ice bath, the precipitates were collected by 
centrifugation at 1600 rpm for 10 minutes in an IEC refrigerated 
centrifuge. 
The precipitates were extracted once with 1 ml of cold methanol 
and three times with 2 ml of chloroform:methanol, 2:1 by volume, at 
20 C, 37 C and 60 C, respectively. The combined extracts were washed 
once with one sixth volume of water and twice with one third volume of 
chloroform:methanol: 0.1% NaCl in water (0.1:1:1) (Hakomori and Murakami, 
1968). 
Washed extracts were evaporated to dryness under N~ and resuspended 
in a small volume of chloroform:methanol (2:1). Aliquots were taken for 
phosphorus determination. Two dimensional chromatography was performed 
on triplicate aliquots on silica gel-precoated glass plates (E. Merck, 
A. G., Darmstadt, Germany). The plates were developed with chloroform: 
methanol:water (65:25:4), air dried for 10 minutes, and then developed in 
a direction 90 to the first with butanol:acetic acid:water (60:20:20) 
(Rouser et al., 1965). 
Dry plates were stained with iodine vapor and the phospholipid-
containing silica gel was scraped from them for phosphorus determination. 
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Protein Determination 
Protein was determined by the method of Lowry et al. (1951) using 
bovine serum albumin (Armour Pharmaceutical Company, Chicago, 111.) in 
the appropriate buffer as a standard. 
Determination of Radioactivity 
Aliquots of cell fractions or whole cells were precipitated with 
an equal volume of cold 10% trichloroacetic acid. After 20 minutes in 
an ice bath, samples were filtered onto Whatman GF/C glass fiber filters 
and washed twice with 5% trichloroacetic acid. Filters were placed in 
glass scintillation vials and dried in a 70 C oven. Ten ml of scintil-
lation fluid was added, and the radioactivity was determined in a Packard 
Tri-carb Scintillation Spectrometer. The scintillation fluid was made 
by adding 160 ml Liquifluor (New England Nuclear, Boston, Mass.) to one 
gallon of toluene (Merck and Company, Rahway, N. J.). 
Chloroform-methanol extracts were dried directly in vials and 
counted in the same scintillation fluid. 
RNA Polymerase Assay 
The reaction mixture, modified from that used by Girard (1969), 
contained 0.05 mmoles Tris, pH 8.5; 4.15 umoles magnesium acetate, 4.0 
jjmoles phosphoenolpyruvate, 10 p.g pyruvate kinase, 0.1 umoles each of 
3 
ATP, CTP and GTP, 25 uCi of H-UTP (17.8 Ci/mmole) and 0.20 ml of the 
enzyme preparation in a final volume of 0.5 ml. Samples were incubated 
in a 36.7 C water bath. The reaction was terminated by the rapid addi-
tion of 0.1 ml of 0.1% bovine serum albumin and 0.6 ml cold 10% trichloro-
acetic acid containing 0.02 M sodium pyrophosphate. The tube was agitated 
on a vortex mixer and plunged into an ice bath. After 20 minutes on ice, 
the tubes were centrifuged at 2000 rpm for 15 minutes in an IEC refriger-
ated centrifuge and the pellets washed twice by resuspension in 0.3 ml 
ice-cold 0.2 N NaOH and reprecipitation with 10% trichloroacetic acid 
with 0.02 M sodium pyrophosphate (Maitra and Hurwitz, 1965). Each time 
the precipitate was kept on ice for 20 minutes before centrifugation. 
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The final precipitate was collected by filtration onto Whatman GF/C glass 
fiber filters and was washed twice with cold 5% trichloroacetic acid 
containing 0.025 M sodium pyrophosphate. Filters were dried and counted 
as described earlier. 
It should be noted that this cell-free polymerase system is a crude 
system which utilizes endogenous template and is not responsive to added 
RNA. The presence of various degradative enzymes, notably ribonuclease, 
complicate the interpretation of results. 
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3. CYTOPLASMIC MEMBRANES IN POLIOVIRUS-INFECTED CELLS 
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Chapter 3 
Cytoplasmic Membranes in Poliovirus-infected Cells 
Introduction 
Poliovirus replication is closely associated with cellular membranes. 
The studies of Caliguiri and Tamm (1969, 1970a,b) showed that the membranes 
of infected cells could be fractionated on a discontinuous sucrose gradient. 
When this is done, viral RNA and viral protein synthesis are separated from 
each other; the two processes are associated with different membranes in 
the infected cell. Because of the close association between the biosyn-
thesis of poliovirus and cellular membranes demonstrated by these experi-
ments, and because the phospholipid and protein contents of these fractions 
differed in uninfected and infected cells (Caliguiri and Tamm, 1970a), we 
decided to study the chemical composition of these membranes throughout 
the course of infection. 
We also investigated the RNA-synthesizing capacity of the membranes 
from the various fractions and demonstrated this activity in a complex 
with a sedimentation constant of 130 S, which may be obtained by lysis of 
the membranes in Fraction 2. 
The gradient used for all of our experiments is shown in Figure 1. 
A cytoplasmic extract, prepared as described in Materials and Methods, is 
mixed gently with an equal volume of 60% sucrose in RSB, and layered into 
the gradient. Gradients are centrifuged at 86,000 x g (Rav) until the con-
tents are at equilibrium. After centrifugation, six opaque bands, centered 
on the previous interfaces in the tube, can be seen. Fraction 1 is a 
fatty, scumlike layer at the air-buffer interface. Fractions 2 through 6 
are the bands pictured in Figure 1, and Fraction 7 consists of the pellet 
plus a small amount of 60% sucrose lying immediately above it. These 
fractions are collected, diluted with RSB and centrifuged at 95,000 x g 
in a Spinco 40 rotor for 2 hours. Electron micrographs of the fractions 
after pelleting are shown in Figures 2 and 3. These micrographs were 









































Figure 1. Schematic representation of discontinuous sucrose gradient 
used to fractionate cell membranes. The bands that are visible after 
centrifugation to equilibrium are indicated in the tube on the right. 
The brackets indicate the fractions. The volumes and densities of each 
fraction in a representative experiment are listed in the two columns 
on the right. (From Caliguiri and Tamm, 1970a) 
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Figure 2. Electron micrographs of the pellets of Fractions 2 through 4 
o 
from poliovirus-infected cells. HeLa cells (5 x 10 ) were infected at 
a multiplicity of 50 PFU/cell in medium containing 5 ug/ml actinomycin D. 
The culture was harvested 3.25 hours after infection and the cells were 
fractionated on a discontinuous sucrose gradient as described in Materials 
and Methods. Fractions were pelleted and prepared for electron microscopy. 
The fraction number appears in the lower left-hand corner of each 
micrograph. Magnification x 40,000. (From Caliguiri and Tamm, 1970a) 
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Figure 3. Electron micrographs of the pellets of Fractions 5 through 7 
from poliovirus-infected HeLa cells. The preparation was made as in 
Figure 2. Magnification x 40,000. (From Caliguiri and Tamm, 1970a) 
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The work of Caliguiri and Tamm (1969, 1970a,b) leads to the con-
clusion that viral RNA synthesis is associated with the fraction labeled 
2 in Figures 1 and 2 by the following criteria. This fraction contains 
3 
most of the labeled RNA after a very short pulse of H-uridine is given 
to infected cells just prior to harvesting. Analysis of RNA extracted 
from this fraction by sedimentation velocity centrifugation or poly-
acrylamide-agarose gel electrophoresis reveals viral replicative inter-
mediate and replicative form RNA, but no completed single-stranded viral 
RNA. And finally, the bulk of the viral RNA polymerase activity deter-
mined in a cell-free assay is found here. This fraction consists of 
smooth microsomes as shown by electron microscopy and by the absence of 
whole ribosomes as determined by sedimentation velocity analysis of 
deoxycholate-treated material from this fraction. When cells are labeled 
3 
with H-uridine for 36 hours prior to infection, and harvested 3.25 hours 
after infection, over 957o of the radioactivity is in ribosomal RNA. Only 
0.3% of the labeled ribosomal RNA sediments in Fraction 2, and the sedi-
mentation constant of labeled material after deoxycholate treatment is 
less than 74 S. This material probably represents ribosomal subunits. 
Enzymatic studies have shown that some 5'-nucleotidase activity (plasma 
membrane marker) also sediments here. However, most of the 5'-nucleo-
tidase activity is sedimented in the low speed centrifugation (see 
Materials and Methods), and thus most plasma membrane fragments are 
never layered into the gradient (Caliguiri, unpublished observations). 
The fraction labeled 5 in Figures 1 and 3 is visualized in the 
centrifuge tube as a thick, coherent pellicle, and electron microscopy 
shows that it contains rough microsomal membranes. When cells are labeled 
3 
with H-uridine for 36 hours prior to infection and harvested 3.25 hours 
after infection, over 50% of the labeled ribosomal RNA is found in this 
fraction. The pellicle fraction contains structures with the sedimenta-
tion characteristics of viral polyribosomes and 3-minute pulses with 
C-labeled amino acid mixture label this fraction preferentially. 
Because of these facts, it is concluded that viral protein synthesis is 
associated with cellular membranes which sediment in the pellicle. 
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This fraction also contains the highest specific activities of cytochrome 
oxidase and p-glucuronidase, and therefore mitochondria and lysosomes 
probably come to equilibrium here (Caliguiri, unpublished observations). 
The findings summarized briefly above are discussed more completely 
by Caliguiri and Tamm (1970a,b). 
Results 
Protein and Phospholipid Analyses of Fractions from Infected Cells 
g 
HeLa cells (7.5 x 10 ) in Eagle's spinner medium were infected with 
28 PFU/cell of poliovirus type 2 in a total volume of 100 ml. After one 
hour the volume was brought to 480 ml with additional warm medium. Note 
that actinomycin D was not used in this experiment. At selected times, 
80 ml aliquots were harvested by pouring over crushed frozen PBS and 
centrifuging to sediment the cells. Cell extracts were prepared as 
described in Materials and Methods and layered into discontinuous sucrose 
gradients. They were centrifuged for 17 hours. The appearance of the 
gradients after centrifugation is pictured schematically in Figure 4. 
The appearance changed progressively with time after infection, and the 
fractions which changed most were precisely those which seem most 
intimately involved in the virus biosynthetic processes. The gradient 
from cells harvested 2.5 hours after infection looked like one produced 
from uninfected cells. As infection continued, Fraction 2 became pro-
gressively more opaque, and the width of the visible band increased. 
The thick pellicle of rough microsomes, indicated in the drawing as a 
heavy black line, came to equilibrium at progressively higher densities. 
At the same time, it became noticeably smaller and less coherent. 
The protein and lipid phosphorus contents of the pelleted fractions 
are listed in Table I. The values for Fraction 1 have been omitted. This 
fraction consisted of a scumlike layer of fatty material which had signifi-
cant quantities of lipid phosphorus, but could not be pelleted or handled 
quantitatively. Its content of lipid phosphorus did not change signifi-
cantly over the course of infection. Its protein content was negligible. 
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Figure 4. Schematic representation of discontinuous sucrose gradients 
prepared from HeLa cells at various times after infection with poliovirus. 
Preparation of gradients is described in text. Times indicated below 
each tube are hours after infection. 
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Table I 






































































































































total 5.648 2.644 .361 
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Table I (Cont.) 






































































































































total 4.555 2.790 .472 
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Changes in Composition of Fraction 2. The most dramatic changes 
were those found in Fraction 2. The protein and phospholipid contents 
of Fraction 2 from the 6 gradients are plotted in Figure 5. These are 
expressed as percent of the total for Fractions 2 through 7 in each 
gradient to minimize sampling error and variation due to the loss of 
damaged cells during processing at late times after infection. Also 
plotted is the phospholipid/protein ratio. In Fraction 2 the protein 
content increased approximately 8-fold and the lipid phosphorus content 
increased 13.4-fold between 2.5 and 6 hours after infection. This re-
sulted in almost a doubling of the phospholipid/protein ratio in this 
3.5-hour period, an indication that the membranes sedimenting in this 
fraction were substantially different at the two times. 
Further evidence for the changing character of these membranes 
may be found in the phospholipid analysis of membranes from Fraction 2 
of uninfected and infected cells. HeLa cells were sedimented and washed 
free of serum. Half of the cells were infected with approximately 50 to 
100 PFU/cell. Uninfected cells were mock-infected with PBS and were 
treated identically to the infected cells throughout. At 5 hours 
after infection, both cultures were harvested and fractionated as 
described in Materials and Methods. Lipids were extracted from each 
fraction and phospholipids were separated by thin layer chromatography. 
The phosphorus content of each spot was determined and the averages of 
results of two experiments, expressed as percents of total phospholipids, 
are shown in Table II. These analyses were performed by Dr. Andreas Scheid. 
The most striking alteration in the phospholipids of Fraction 2 
which occurred after infection was the sharp decrease in sphingomyelin 
content. This change was regularly observed. The decrease in sphingo-
myelin content is accompanied by an increase in the proportion of 
phosphatidylcholine present. The somewhat smaller change in lysophos-
phatidylethanolamine plus phosphatidylinositol content has not proven to 
be reproducible. There are no significant changes in the phospholipid 
composition of whole cells or of Fraction 3 as a result of infection. 
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Figure 5. Protein and phospholipid content of Fraction 2 from poliovirus-
infected HeLa cells. HeLa cells were infected and fractionated on discon-
tinuous sucrose gradients at various times after infection. Protein and 
lipid phosphorus were determined. Values for lipid phosphorus were con-
verted to phospholipid as described in Materials and Methods. Both protein 
and phospholipid are plotted as % of the total for each gradient. 
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Table II 
Percentage Phospholipid Distribution in Fractions 2 and 3 
of Poliovirus-infected HeLa Cells and Uninfected Cells 
Controls 
Whole Frac- Frac-
cells tion 2 tion 3 
Infected 
Whole Frac- Frac-
cells tion 2 tion 3 
Lyso-phosphatidyl-
choline 10.1 10.2 7.9 9.6 10.0 8.2 
Sphingomye1in 6.1 11.7 16.0 5.9 3.8 14.9 
Phosphatidyl-
choline 52.7 46.5 38.3 54.3 59.6 39.9 
Phosphatidyl-
serine 8.0 14.9 18.5 8.3 14.7 18.3 
Lyso-PE/PI 7.0 8.5 10.1 6.5 4.4 10.1 
Phosphatidyl-
ethanolamine 16.1 8.0 9.3 15.3 7.5 8.5 
Total 100.0 99.8 100.1 99.9 100.0 99.9 
Lipid-P/protein 
(mumoles/mg) 118.5 1539. 503.5 140.5 2830. 533.0 
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Changes in Composition of Other Fractions. In contrast to the 
marked changes in the mass and composition of membranes in Fraction 2, 
changes in the other fractions were small (Table I). The protein and 
phospholipid content of Fraction 3 remained quite uniform throughout the 
course of infection as seen in Figure 6. Fraction 4 increased in mass 
and its phospholipid/protein ratio doubled in this experiment; in other 
experiments these changes were not as great. It should be emphasized 
that the changes in Fraction 2 described above were highly reproducible. 
The changes in Fractions 5 and 6 were related to the changing size 
and position of the pellicle. It was collected in Fraction 5 from the 
first 3 gradients in the series, and in Fraction 6 from the last 3. The 
totals of the protein and phospholipid contents of both fractions are 
plotted in Figure 6. Here it is apparent that the total mass of the 
pellicle did decrease, but the phospholipid/protein ratio remained 
fairly stable. The apparent increase in density might be due to varia-
tion in RNA content of the pellicle. 
The protein and phospholipid contents of Fraction 7 were highly 
variable and have proven to be so over the course of many experiments. 
The composition of this fraction, which appears in electron micrographs 
to consist of ribosomes without recognizable membranes, may be influenced 
greatly by small differences in cell physiology or in the processing 
procedures. 
Poliovirus RNA Polymerase in Membranes from Fraction 2 
A major difference between the membranes which sediment in Fraction 
2 in gradients prepared from infected and uninfected cells is the associa-
tion of the viral RNA polymerase with membranes from infected cells. This 
association is firm enough to withstand pelleting or recentrifugation on 
continuous sucrose or tartrate gradients, and is broken only by treatment 
with deoxycholate and lysis of the membrane. 
Figure 7 shows the RNA polymerase activity associated with the 
microsomal fraction of infected cells. HeLa cells were infected with 140 



















^ ~ ^ ^ - _ 
o- o_-o--o--o ° 
















° — -o--a--o--o -° 
J I I L. 
-o- -o*^--o- o -o-
2 4 
Hours 
Figure 6. Protein and phospholipid content of Fraction 3 and Fractions 
5 plus 6 from poliovirus-infected HeLa cells. The preparation was made 
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Figure 7. Kinetics of in vitro RNA polymerase activity in poliovirus-
o 
infected and uninfected HeLa cells. HeLa cells (3.2 x 10 cells) were 
divided into 2 cultures. One was infected with 140 PFU/cell of polio-
virus type 2. Both were harvested 4 hours later. Cytoplasmic extracts 
were prepared and centrifuged at 95,000 x g for 1 hour. Pellets were 
resuspended in 4 ml of polymerase buffer and centrifuged at 2000 rpm 
for 10 minutes. The supernatants were assayed for RNA polymerase ac-
tivity as described in Materials and Methods. , uninfected cells; 
o o, infected cells. 
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extracts were prepared and centrifuged at 95,000 x g for one hour. The 
pellet was resuspended in polymerase buffer and used in a cell-free 
assay for RNA polymerase activity. The preparation from infected cells 
3 
demonstrated linear incorporation of H-UTP for one hour. An identical 
preparation from uninfected cells contained no demonstrable RNA polymer-
ase activity. 
When cells were fractionated in a discontinuous sucrose gradient, 
the highest specific activity was found in Fraction 2, as shown in 
Table III. This confirms the previous results of Caliguiri and Tamm 
(1969). 
If membranes from Fraction 2 of infected cells are mixed with 
deoxycholate and centrifuged in a gradient of 15-30% sucrose in RSB at 
86,000 x g (Rav) for 90 minutes in a Spinco SW27 rotor, a complex with 
an estimated sedimentation constant of 130 S may be detected which con-
tains pulse labeled viral RNA (Caliguiri and Tamm, 1970b). We have 
demonstrated that this complex also contains viral RNA polymerase 
activity. 
o 
HeLa cells (3.2 x 10 cells) were infected with 150 PFU/cell of 
poliovirus type 2 and divided into two portions. One culture received 
3 
5 jig/ml actinomycin D at one hour after infection and 1.0 mCi of H-
uridine at 3 hours 55 minutes after infection. The other culture 
received neither. At 4 hours after infection, both cultures were 
harvested by pouring over crushed frozen PBS, and centrifuged to sedi-
ment cells. Cytoplasmic extracts were prepared and centrifuged in dis-
continuous sucrose gradient as described in Materials and Methods. 
Fraction 2 was collected from each gradient and pelleted by centrifuga-
tion at 95,000 x g for 2 hours. Some material from the unlabeled 
gradient was refrigerated for use in the RNA polymerase assay. The 
pellets were resuspended in 1.0 ml of 2.0% deoxycholate in RSB and 
layered onto 15-30% linear sucrose gradients. These were centrifuged 
for 90 minutes at 86,000 x g (Rav) in a Spinco SW27 rotor and 1.0 ml 
fractions were collected by pumping 45% sucrose into the bottom of the 
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Table III 
In Vitro RNA Polymerase Activity in Fractions 
from Poliovirus-infected HeLa Cells 
3 
cpm uumole H-UTP 
incorporated mg protein mg protein 
Cell extract 34,749 .896 3.88 
Fraction 2° 43,528 .093 46.85 
Fraction 3 8,050 .076 10.71 
Fraction 4 7,220 .100 7.22 
Fraction 5 8,029 .195 4.12 
Fraction 6 2,384 .058 4.11 
Incubated for one hour. 
Infected culture harvested at 4 hours after infection. 
100,000 x g pellets of fractions collected after centrifugation in 
discontinuous sucrose gradient as described in Materials and Methods. 
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tubes. The replication complex, with a sedimentation constant of approx-
imately 130 S, was located by assaying each fraction from the labeled 
gradient for acid-precipitable radioactivity. The results are shown in 
Figure 8. Fractions from the unlabeled gradient corresponding to the 
peak of radioactivity in the labeled gradient (bracketed in Figure 8) 
were pooled and assayed for RNA polymerase activity. Our experiments 
3 
have shown that the H-uridine label and RNA polymerase activity are dis-
tributed identically in such a gradient. The activity of the pooled 
fractions was compared to the activity of the membrane-bound complex in 
Fraction 2 and to Fraction 2 material prepared identically from unin-
fected cells. These results are shown in Table IV. The specific 
activity of the released 130 S complex and the kinetics of incorporation 
3 
of H-UTP into this complex are very similar to the specific activity 
and kinetics for the membrane-bound replication complex from infected 
cells. Note that in neither case is the incorporation linear for an 
hour; since we have shown that the product of this system is primarily 
ribonuclease-resistant double-stranded RNA, it is possible that nuclease 
contamination is responsible for non-linearity of precursor incorporation. 
This experiment has demonstrated viral RNA polymerase activity in the 
130 S complex released from membranes in Fraction 2 from infected cells. 
Discussion 
The distribution of cytoplasmic membranes into fractions with dif-
ferent densities changes with time after infection of HeLa cells with 
poliovirus. These changes are most evident as a marked increase of mem-
branes with low density and as a decrease in quantity and increase in 
density of the rough microsomal membranes which form a pellicle in the 
discontinuous sucrose gradient used for fractionation. 
Viral RNA synthesis is associated with the low density membranes 
found in Fraction 2 (Caliguiri and Tamm, 1970a,b). We consider that 
these membranes are identical to the proliferating smooth membrane-bound 
cisternae seen in electron micrographs of picornavirus-infected cells 










Figure 8. Localization and isolation of the 130 S replication complex 
for viral RNA polymerase assay. HeLa cells were infected and fraction-
ated as described in the text. Deoxycholate-treated pellets from 
3 
Fraction 2 of an unlabeled culture and a culture labeled with H-
uridine for 5 minutes were centrifuged in 15-30% sucrose-RSB gradients 
at 86,000 x g for 90 minutes. The peak of acid-precipitable radio-
activity of the labeled gradient shows the location of the replication 
complex. Fractions of the unlabeled gradient corresponding to those 
bracketed in the labeled gradient were pooled and used for an in vitro 
polymerase assay as the 130 S complex. 
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Table IV 
In Vitro RNA Polymerase Activity in the 



































Infected cells harvested at 4 hours after infection. 
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shown that they are smooth cytoplasmic membranes (Caliguiri and Tamm, 
1970a; see Figure 2). The time course of the increase in protein and 
phospholipid content of this fraction, plotted in Figure 5, corresponds 
well with the development of smooth-walled cisternae in thin-sectioned 
poliovirus-infected cells. Dales and co-workers (1965) found few of 
these bodies at 3 hours after infection, and increasing amounts at 5 
and 7 hours after infection. 
It is interesting that these membranes continue to accumulate 
late into infection, well beyond the peak of viral RNA synthesis, which 
occurs between 3.5 and 4 hours after infection as measured in a cell-
3 
free assay system (Baltimore et al., 1963) or by short H-uridine pulses 
in intact, infected cells (Caliguiri and Tamm, 1968a). This indicates 
that continuing rapid viral RNA synthesis is not necessary for the 
appearance of membranes in this fraction. 
The phospholipid analysis of Fraction 2 (Table II) demonstrates 
that these membranes are qualitatively as well as quantitatively differ-
ent in infected and uninfected cells. The very low sphingomyelin con-
tent which is the most striking change is indicative, incidentally, of 
a lack of contamination of this fraction by plasma membrane fragments, 
most of which are sedimented by the low speed centrifugation prior to 
layering the samples into the gradients. Plasma membranes are relative-
ly rich in sphingomyelin (Fleischer and Rouser, 1965; Klenk and Choppin, 
1970). The membranes of Fraction 2 from infected cells demonstrate an 
extremely low content of this phospholipid, considerably lower than most 
analyses of microsomal membranes have indicated (Dallrer et al., 1965b; 
Fleischer and Rouser, 1965). 
The lysophosphatidylcholine contents listed in Table II are quite 
high. Analysis of cell extracts that were frozen immediately after pre-
paration has confirmed that these values are not the result of degradation 
of phosphatides during storage. We consider that these values are not 
artifacts of the method used for phospholipid analysis, since previous 
experience has shown the method to be reliable. 
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The pellicle of rough microsomes with which viral protein synthe-
sis is associated decreases in size and increases in density as infection 
progresses. These changes might be related to late events in the viral 
growth cycle or to the action of lysosomal enzymes that may be released 
in poliovirus-infected cells (see Chapter 1). 
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4. SYNTHESIS OF CELLULAR MEMBRANE PHOSPHOLIPIDS -
INCORPORATION OF 3H-CHOLINE AND 3H-GLYCEROL 
48 
Chapter 4 
Synthesis of Cellular Membrane Phospholipids -
3 3 
Incorporation of H-Choline and H-Glycerol 
Introduction 
We have demonstrated that poliovirus infection produces striking 
changes in the quantity and composition of certain membranes in its host 
cell, and that these membranes may be separated on the basis of their 
densities. It was of interest to investigate the synthesis of the phos-
pholipids of these membranes not only because it represents a case of 
viral control of cellular synthesis, but especially because of the rapid 
accumulation of the membranes which sediment in Fraction 2, with which 
viral RNA synthesis is associated. 
As mentioned in Chapter 1, poliovirus infection leads to a marked, 
rapid decline in cellular protein synthesis. Slightly later in the viral 
3 
cycle, at about 3 hours after infection, the incorporation of H-choline 
into macromolecular structures is stimulated in infected cells. This 
stimulation requires some protein synthesis. However, treatment of 
infected cells with actinomycin D does not abolish the stimulation of 
choline incorporation (Penman, 1965), and thus the synthesis of cellular 
messenger RNA is not required. In fact, Amako and Dales (1967b) found 
that they had to treat both infected and uninfected cells with actinomycin 
D to "unmask" the stimulated synthesis in mengovirus-infected L cells. 
Drug treatment lowered the incorporation of choline in both groups of 
cells, but the effect was greater in uninfected cells. We did not use 
actinomycin D in the experiments discussed in this chapter. 
The usefulness of choline as a label for membrane phospholipids 
has been demonstrated in intact animals (Nagley and Hallinan, 1968) and 
in cell culture (Amako and Dales, 1967b; Plagemann, 1968). In all of 
these studies 90% or more of C- or H-labeled choline that was incor-
porated could be detected in membrane lipids. Thin layer chromatography 
of lipid extracts have shown that in our experiments, after 2 hours of 
labeling poliovirus-infected and uninfected cells with 3H-choline, 
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about .94% of the label is in phosphatidylcholine, 5% is in lysophosphatidyl-
choline, and 1% or less in sphingomyelin. 
It is not possible to perform pulse-chase experiments using very 
short pulses of labeled choline in most animal cells (Amako and Dales, 
1967b; Plagemann, 1968). Apparently, choline enters an expandable intra-
cellular pool which is not exchanged with the extracellular medium. 
Plagemann (1968) has presented evidence that in Novikoff rat hepatoma 
cells, the nonexchangeable pool consists primarily of phosphorylcholine. 
3 
To overcome this difficulty, we have used glycerol-2- H to demonstrate 
the precursor-product relationships between membrane components in the 
rough and smooth membranes of infected cells. 
Results 
3 
Labeling of Cellular Membrane Fractions with H-choline in Infected and 
Uninfected Cells. 
o 
HeLa cells (3.6 x 10 cells) from suspension culture, were sedimented, 
washed and resuspended in cold Eagle's spinner medium. Half of the cells 
were infected with 60 PFU/cell of poliovirus type 2. Both cultures were 
incubated at 37 C. One hour later both cultures were diluted with warm 
3 
spinner medium. At 3.5 hours after infection, 0.5 mCi of H-choline was 
added to each culture and 30 minutes later they were harvested by pouring 
over crushed frozen PBS. The cells were sedimented and washed with cold 
3 
PBS to remove H-choline from the medium, and discontinuous sucrose-RSB 
gradients were prepared as described in Materials and Methods. After 
centrifugation for 17 hours, fractions were collected from the top using 
a specially designed fraction collector. The fatty material from the top 
of the gradient was removed in a volume of 1 ml and the rest of the gradient 
was collected in 3 ml fractions. The fractions were diluted with RSB and 
membranes were pelleted by centrifugation at 95,000 x g for 2 hours in a 
Spinco S40 rotor. Pellets were resuspended 'n 1.0 ml RSB and analyzed for 
protein, lipid phosphorus and lipid-associated radioactivity. We collected 
fractions of uniform volume in this experiment to eliminate technical 
problems that could be introduced by manual collection of visualized bands. 
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There was good agreement between results obtained using the two col-
lection methods. 
The results of the protein and lipid phosphorus analyses are 
plotted in Figures 9 and 10, respectively. Note that the lipid 
phosphorus values have been converted to mg of phospholipid, based on 
an average molecular weight of 770 for the "typical" phospholipid. 
There was an increased amount of both protein and phospholipid in the 
upper fractions of the infected gradient, where the smooth microsomes 
of Fraction 2 would sediment. 
Figure 11 shows the total radioactivity which was extracted into 
chloroform-methanol from the pelleted fractions. Again, there was a 
definite increase in radioactivity in the upper fractions from the 
sucrose gradient prepared from the cytoplasmic extract of infected cells. 
It should be noted that the total radioactivity in the entire gradient 
from infected cells exceeded the total in the gradient from uninfected 
cells by 67%, although this is not immediately obvious in Figure 11. 
Division of the lipid-associated radioactivity in each fraction 
by the amount of phospholipid per fraction yields the results plotted 
in Figure 12. In uninfected cells, the highest activities were in the 
fractions corresponding to the pellicle of rough membranes. In infected 
cells the distribution of radioactivity was bimodal, indicating stimu-
lation of synthesis of membranes which sediment in the upper part of the 
gradient. 
This method of presenting the data gives a figure which is 
analogous to a specific activity, although a greater amount of radio-
activity per mg phospholipid could be achieved either by a generalized 
stimulation of phospholipid synthesis or by a specific stimulated 
production of those phospholipid molecules that contain the choline 
label. Our studies and those of Plagemann (1968) and Nagely and 
3 
Hallinan (1968) have shown that H-choline label is found largely in 
phosphatidylcholine, with minor quantities in lysophosphatidylcholine 







Figure 9. Protein content of fractions from discontinuous sucrose 
gradients from uninfected and infected HeLa cells harvested 4 hours 
after infection with poliovirus. HeLa.cells were infected, labeled 
and fractionated as described in the text. The fractions were 
pelleted by centrifugation at 95,000 x g for 2 hours. Protein was 
determined for each fraction. Top of the gradients is on the left. 
. ., uninfected cells; o o, infected cells. 
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Figure 10. Phospholipid content of fractions from discontinuous sucrose 
gradients from uninfected and infected HeLa cells harvested 4 hours 
after infection with poliovirus. Preparation is as described for Figure 
9. Lipid phosphorus was determined for each pelleted fraction and the 
values converted to phospholipid as described in Materials and Methods. 





Figure 11. Lipid associated H-choline radioactivity of fractions from 
discontinuous sucrose gradients from uninfected and infected HeLa cells 
harvested 4 hours after infection with poliovirus. Fractions were pre-
pared as described for Figure 9. Radioactivity extracted by chloroform-
methanol was determined. Top of gradients is on the left. 







Figure 12. Lipid-associated H-choline radioactivity per mg phospholipid 
of fractions from discontinuous sucrose gradients from uninfected and in-
fected HeLa cells harvested 4 hours after infection. Values were calcu-
lated as described in the text. Top of the gradients is on the left. 
. ., uninfected cells; o o, infected cells. 
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of the different phospholipids is significantly altered in Fraction 2 
after 5 hours of infection, it is probable that some of the increased 
radioactivity per mg of phospholipid in this part of the gradient re-
flects the relative increase in phosphatidylcholine compared to other 
phospholipids. However, the increase in phosphatidylcholine is not 
large enough to account for all of the excess radioactivity, and we may 
assume that the incorporation of phospholipids is increased in general. 
This has been demonstrated for the entire cell. Cornatzer (1961) found 
that 4 hours after infection with poliovirus the specific activities of 
32 
all phospholipids from HeLa cells labeled for 30 minutes with P were 
increased in comparison with those from uninfected cells. 
Synthesis of Cellular Membranes Late in the Viral Growth Cycle 
It was of interest to determine whether this stimulation of 
choline incorporation into cellular membranes, and preferential synthesis 
of certain membranes would continue late into infection. For this pur-
o 
pose 8.3 x 10 cells were centrifuged, washed and resuspended in serum-
free medium in two equal portions. One was infected with 100 PFU/cell 
of poliovirus type 2, and both were incubated at 37 C. After one hour 
both were diluted to 100 ml with warm Eagle's spinner medium. At 5 
3 
hours after infection, 0.3 mCi of H-choline was added to each culture. 
Three minutes later one half of each culture was harvested by pouring 
over crushed frozen PBS. At 5.5 hours after infection the remainder of 
each culture was harvested in the same way. Discontinuous sucrose 
gradients were prepared and centrifuged, as described in Materials and 
Methods. The visible bands were collected manually. 
The radioactive counts extracted into chloroform-methanol from 
each pelleted fraction are plotted in Figure 13. After a 3-minute pulse 
3 
most of the H-choline label was found in the pellicle of rough micro-
somal membranes: Fraction 5 in uninfected cells, and Fraction 6 in 
infected cells, indicating that phosphatidylcholine is incorporated into 
membranes in this fraction. After 30 minutes of incorporation, this was 
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Figure 13. Lipid-associated H-choline radioactivity from fractions 
of discontinuous sucrose gradients from uninfected and infected HeLa 
cells late in the viral cycle. Cells were infected, labeled and 
fractionated as described in the text. Pelleted fractions were ex-
tracted with chloroform-methanol and the extracts were assayed for 
radioactivity. 
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cells was now associated with the smooth membranes which sedimented in 
Fraction 2. In fact, comparison of the relative amount of radioactivity 
incorporated into Fraction 2 of infected cells in this experiment with 
incorporation during half hour pulses at earlier times in the virus cycle 
indicated that approximately as many of the newly incorporated choline 
molecules sedimented in Fraction 2 at 5.5 hours after infection as at 
3.5 or 4 hours after infection. Over the course of the full half hour, 
the infected cells incorporated three times as much radioactivity as did 
uninfected cells. 
When the radioactivity of each fraction is divided by the phos-
pholipid content of the fraction, the results are shown in Figure 14. 
Only the values for infected cells are shown. It is clear from these 
results that incorporation occurred most rapidly into Fractions 5 and 6, 
both of which contained material from the original pellicle fraction. 
After 30 minutes of labeling there was no peak of activity in the upper 
part of the gradient as there was in the results discussed earlier, but 
it must be remembered that a large quantity of material has accumulated 
here by 5.5 hours after infection. This mass of unlabeled phospholipid 
reduced the calculated activity for Fraction 2 even though newly syn-
thesized phospholipids are found here in quantities as large as at 
earlier times in the viral cycle. 
The continued incorporation of choline and the accumulation of 
membranes in Fraction 2 occurs at a time when cellular nucleic acid and 
protein synthesis have been greatly reduced for several hours (Zimmerman 
et al., 1962; Holland and Peterson, 1964; Penman and Summers, 1965). In 
fact, pathological rounding of cells has also occurred in a large propor-
tion of the cells. Viral RNA synthesis has declined markedly by 5 to 5.5 
hours after infection (Baltimore et al., 1963). The products of viral 
protein synthesis, however, are still present in large quantities. 
3 
Pulse-Chase Labeling of Cellular Membranes with Glycerol-2- H 
3 
Glycerol-2- H labels lipids containing the glycerol backbone. 
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Figure 14. Lipid-associated H-choline radioactivity per mg of phospho-
lipid of fractions from discontinuous sucrose gradients from infected 
HeLa cells late in the viral cycle. Cells were infected, labeled and 
fractionated as described in the text. Pelleted fractions were analyzed 
for lipid-associated radioactivity and lipid phosphorus. Values for 
lipid phosphorus were converted to phospholipid as described in Materials 
and Methods and divided into the lipid-associated counts for each fraction, 
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incorporated into substances extracted by chloroform-methanol. Since 
labeled glycerol molecules can be effectively chased by removal of the 
labeled medium, we used glycerol as a tracer for studies on the origin 
of the lipids in the smooth membranes of Fraction 2. 
o 
Sg HeLa cells in suspension (5 x 10 cells) were washed and 
divided into 2 cultures, of which one was infected with 70 PFU/cell of 
poliovirus type 2. After one hour at 37° C, both cultures were diluted 
to 100 ml with warm Eagle's spinner medium. At 3 hours and 27 minutes 
3 
after infection, 0.3 mCi of glycerol-2- H (approximately 0.8 umoles) was 
added to each culture. Three minutes later, half of each culture was 
harvested by pouring over crushed frozen PBS. Cell extracts were pre-
pared and fractionated in discontinuous sucrose gradients. The remain-
der of each culture was poured over 100 ml warm Eagle's spinner medium 
containing 10 mmoles of unlabeled glycerol. The cells were sedimented 
by centrifugation, resuspended in 50 ml warm, unlabeled medium, and 
returned to 37 C. At 4.5 hours after infection these cells were 
harvested. Cell extracts were prepared and fractionated in discontinu-
ous sucrose gradients. Visible bands were collected manually from the 
top. 
Radioactivity extracted into chloroform-methanol from the pelleted 
fractions is shown in Figure 15. Note the great increase in incorpora-
tion of glycerol in infected cells compared to uninfected cells. As 
3 
seen when H-choline is used as a label, after the 3-minute pulse, most 
of the radioactivity in both uninfected and infected cells was found in 
the rough microsomal membranes in Fraction 5. In uninfected cells the 
distribution of radioactivity did not change significantly during the 
hour-long chase period. However, in infected cells, a large amount of 
the label was shifted from the rough microsomal pellicle, in Fraction 6 
in this gradient, into the smooth membranes at the top of the gradient, 
particularly those in Fraction 2. Identical results were obtained in 
another experiment in which the cells were maintained, during the chase 
period, in an excess of unlabeled glycerol (1.0 mM) , which prevented the 
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Figure 15. Lipid-associated glycerol-2- H radioactivity of fractions 
from discontinuous sucrose gradients from uninfected and infected HeLa 
cells. Cells were infected, labeled and fractionated as described in 
the text. Pelleted fractions were extracted with chloroform-methanol 
and the extracts were assayed for radioactivity. 
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Thus it appears that in poliovirus-infected cells there is prefer-
ential synthesis in the rough endoplasmic reticulum of lipid which is 
destined to become part of the smooth membranes in Fraction 2. 
Tnhibition of Viral RNA Synthesis - Effect on Choline Incorporation 
Since viral RNA synthesis is associated with the smooth membrane 
of Fraction 2, it was of interest to study the effect of inhibition of 
viral RNA synthesis on the incorporation of choline into various frac-
tions of infected cells. We chose guanidine hydrochloride as a specific 
inhibitor of viral RNA synthesis which would not directly alter the rest 
of the system in any measurable way. As discussed in Chapter 1, we 
already knew several pertinent facts about the action of guanidine. 
Treatment of infected cells with 1.0 to 2.0 mM guanidine completely 
halts viral RNA synthesis. Viral protein synthesis is unaffected except 
by limitation of viral messenger RNA as a result of blocked RNA synthe-
sis. Penman (1965) showed that the stimulation of choline uptake into 
macromolecular structures in infected cells is not abolished by guani-
dine treatment if the cells have been infected with a large enough 
multiplicity of virus. He also showed that guanidine treatment has no 
observable effect on choline incorporation into uninfected cells. We 
have found that treatment of uninfected cells with 1.0 to 2.0 mM 
guanidine either reduces slightly the incorporation of choline or has 
no significant effect. 
Other authors have shown that guanidine prevents or delays the 
development of cytopathic effects in picornavirus-infected cells 
(Bablanian et al., 1965a) and Dales et al. (1965) observed that the 
small smooth surfaced cisternae, which we believe correspond to the 
membranes of Fraction 2, did not develop in cells which had been treated 
with guanidine. Their experiments were performed using 23 PFU/cell of 
poliovirus. Since guanidine treatment blocks viral RNA production, this 
relatively small inoculum may not provide sufficient viral messenger RNA 
to code for the product active in stimulating phospholipid synthesis. 
62 
Penman (1965) found that the stimulation of choline incorporation is 
greatly depressed by guanidine treatment if the cells are infected with 
only 10 PFU/cell of poliovirus. 
To investigate the effect of guanidine treatment on incorporation 
of choline and the accumulation of smooth membranes in Fraction 2, cells 
were infected with a somewhat higher virus multiplicity. HeLa cells 
o 
(6.6 x 10 ) were sedimented, washed and divided into 3 equal portions. 
Two of these were infected with 45 PFU/cell of poliovirus type 2, and 
a third served as a control. After one hour at 37° C, all were diluted 
to 100 ml with warm spinner medium. At this time one of the infected 
cultures was brought to a final concentration of 1.0 mM guanidine. At 
3 
3.5 hours after infection, 0.3 mCi of H-choline was added to each, 
and they were harvested at 4 hours after infection by pouring over 
crushed frozen PBS. Cells were sedimented, and cytoplasmic extracts 
were prepared and layered into discontinuous sucrose gradients as des-
cribed in Materials and Methods. After centrifugation for 9.4 hours, 
the visible bands were collected manually from the top. They were 
pelleted and the resuspended pellets were analyzed for lipid phosphorus 
and radioactivity. Results are plotted in Figures 16-18. The unin-
fected control cultures and the infected cells which were not treated 
with guanidine behaved as in previous experiments with one exception: 
the pellicle of rough microsomal membranes in the uninfected cells sedi-
mented in Fraction 6. This was an infrequent occurrence for which we 
have no explanation. Infected cells which had been treated with guani-
3 
dine incorporated 82% more H-choline than did uninfected control cells. 
Infected cells not treated with guanidine incorporated 120% more choline 
than did uninfected control cells. Thus, both infected cultures demon-
3 
strated marked stimulation of H-choline incorporation. However, in in-
fected cells that had been treated with guanidine, the relative amount 
of radioactivity incorporated into Fraction 2 is similar to that found 
in uninfected cells. The lipid phosphorus analysis (Figure 16) shows 
even more strikingly that there was no extensive accumulation of smooth 
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Figure 16. Effect of guanidine treatment on lipid phosphorus content 
of fractions from discontinuous sucrose gradients from uninfected and 
infected HeLa cells. Cells were infected, treated and fractionated 
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Figure 17. Effect of guanidine treatment on lipid-associated H-
choline radioactivity of fractions from discontinuous sucrose 
gradients from uninfected and infected HeLa cells labeled for 30 
3 
minutes with H-choline. Cells were infected, treated and frac-
tionated as described in the text. Pelleted fractions were 
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Figure 18. Effect of guanidine treatment on lipid-associated H-
choline radioactivity per mg of phospholipid from fractions of 
discontinuous sucrose gradients from uninfected and infected HeLa 
3 
cells labeled for 30 minutes with H-choline. Cells were infected, 
treated and fractionated as described in the text. Pelleted frac-
tions were analyzed for lipid phosphorus and radioactivity extrac-
table by chloroform-methanol. Lipid phosphorus values were con-
verted to phospholipid and divided into the lipid-associated 
counts for each fraction. 
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3 
Distribution of H-Choline Label After a Three-Hour Pulse 
These results were confirmed in the following experiment, which 
3 g 
utilized a longer exposure to H-choline. HeLa cells (9.3 x 10 cells) 
were sedimented, washed and divided into 3 equal portions. Two of these 
were infected with approximately 100 PFU/cell of poliovirus type 2. In 
this experiment, guanidine was added to a final concentration of 1.5 mM 
in one of the infected cultures at one hour after infection when all 
3 
three cultures were diluted to 100 ml with warm spinner medium. H-
Choline (0.3 mCi/culture) was added to all three cultures at 1.5 hours 
after infection, and duplicate aliquots were withdrawn and precipitated 
with cold 10% trichloroacetic acid at half hourly intervals thereafter. 
The counts in each precipitated aliquot, averaged for each pair, are 
plotted in Figure 19. It may be seen that in this case guanidine dimin-
ished the extent to which choline incorporation was stimulated by polio-
virus infection, but it was still marked in the guanidine-treated cul-
ture by 3.5 to 4.5 hours after infection. It should be noted that 
control experiments have shown that guanidine treatment of uninfected 
cells does not lead to increased choline incorporation. 
At 4.5 hours after infection the cells were harvested and frac-
tionated on discontinuous sucrose gradients as described earlier. 
Figure 20 shows the phospholipid content of each fraction from the 
gradients of the two infected cultures, and Figure 21 shows the lipid-
associated radioactivity. Again, the pattern of membrane phospholipids 
and incorporated counts from the guanidine-treated culture resembled 
uninfected cells far more than infected cells. Early guanidine treat-
ment seemed to block almost completely the formation of the smooth 
microsomal membranes which are found in Fraction 2 of gradients from 
infected cells, even though it diminished only partially the stimulation 













p* (1.5 mM) 
Control 
Hours 
Figure 19. H-Choline incorporated into acid-precipitable structures 
in infected and uninfected HeLa cells. Cells were infected and treated 
as described in the text. Duplicate aliquots were withdrawn, precipi-
tated with trichloroacetic acid and analyzed for radioactivity. Values 
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Figure 20. Effect of guanidine treatment on phospholipid content of 
fractions from discontinuous sucrose gradients of poliovirus-infected 
HeLa cells. Cells were infected, treated and fractionated as des-
cribed in the text. Pelleted fractions were analyzed for lipid phos-
phorus. Values for lipid phosphorus were converted to phospholipid 
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Figure 21. Effect of guanidine treatment on lipid-associated radio-
activity of fractions from poliovirus-infected HeLa cells labeled 
3 
for 3 hours with H-choline. Cells were infected, treated and 
fractionated as described in the text. Pelleted fractions were 
analyzed for radioactivity extractable by chloroform-methanol. 
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Discussion 
The results presented in this chapter confirm Penman's (1965) 
findings that poliovirus infection leads to increased incorporation of 
3 , _ . 
H-choline into cellular membranes. A comparison of the radioactivity 
per mg phospholipid incorporated into each fraction after a 30-minute 
labeling period shows that the smooth surfaced cisternae that sediment 
in Fraction 2 contain a proportionately greater share of the counts, 
indicating preferential synthesis. The rough membranes which sediment 
in the pellicle also contain relatively more radioactivity per mg of 
phospholipid, but since the label is being incorporated into membranes 
in this fraction at a more rapid rate than in other fractions, the 
high activity does not necessarily represent preferential synthesis of 
rough microsomal membranes. 
3 
Results of pulse-chase studies with glycerol-2- H suggest that 
the smooth membranes with which viral RNA synthesis is associated are 
produced in the rough endoplasmic reticulum. Incorporation of 
3 
glycerol-2- H is greatly increased as a result of poliovirus infection. 
Treatment of cells with guanidine at one hour after infection 
3 
diminishes but does not block the stimulation of H-choline incorpora-
tion. Yet such cells do not produce great quantities of smooth surfaced 
membranes which sediment in Fraction 2; in fact, their complement of 
membranes appears to be quite similar to that of uninfected cells. This 
suggests that effects of poliovirus infection on cell membrane synthesis 
may operate on two levels: incorporation of precursors, and the conver-
sion of rough to smooth-surfaced membranes. The production of smooth-
surfaced cisternae may depend on the continued production of large 
amounts of certain viral products, which cannot take place in cells 
treated with guanidine before quantities of viral messenger RNA can be 
produced. The increased choline incorporation may be triggered by 
smaller amounts of the same viral product or by an entirely different 
mechanism. 
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Chapter 5 
Blocking of Guanidine Action on Poliovirus Multiplication 
Introduction 
As discussed in Chapter 1, the action of guanidine on poliovirus 
multiplication may be blocked by treatment of cells with choline, 
methionine or many other compounds. To characterize the blocking phe-
nomenon in greater detail, we have investigated the kinetics of polio-
virus replication after blocking the inhibitory action of guanidine with 
choline or dimethylethanolamine. Three cell types were used for this 
study; all were maintained as monolayer cultures. HeLa cells are a con-
tinuous line derived from a human cervical carcinoma and are a different 
subline from the S« HeLa cells grown in suspension culture which were 
used for the experiments described in Chapters 3 and 4. LLC-MK« cells 
are a continuous line derived from rhesus monkey kidney cells. Primary 
rhesus monkey kidney cells (MKC) were also used. 
Preliminary information was needed before kinetic experiments 
could be performed. Knowledge of the effect of the medium used during 
experiments on guanidine inhibition was necessary since most nutrient 
media contain compounds capable of blocking or reducing guanidine inhi-
bition. We also needed to know the effects on virus yield of different 
concentrations of guanidine and choline in the three cell types used. 
Results 
Effect of the Medium 
The virus-inhibitory activity of guanidine may be influenced by 
the culture medium if those components of the medium which possess anti-
guanidine activity are present in sufficient concentration. MEM, which 
was used for most of the experiments reported in this paper, contains 
choline and several amino acids that are guanidine antagonists. There-
fore, preliminary experiments were performed to determine the effect of 
this medium on the inhibitory action of guanidine. MEM was compared 
with Earle's balanced salt solution plus glucose and glutamine (ESG) 
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(Eagle and Habel, 1956); the latter medium contains no compounds with 
known antiguanidine activity. The growth medium on one half of the cul-
tures was changed to ESG at 12 hours prior to infection. After infection 
with poliovirus at 40 PFU/cell, these cultures were again incubated in 
ESG, whereas the remaining cultures were incubated in MEM. At 1.5 hours 
after infection appropriate solutions were added to give final concen-
trations of guanidine and choline as shown in Table V. 
The results summarized in Table V show that, while yields of polio-
virus were reduced by approximately 50% in ESG, the effects of guanidine 
or guanidine plus choline were similar to those in cultures incubated in 
MEM. It may be concluded that the concentrations of potential guanidine 
antagonists in MEM are too low to affect measurably the activity of 
guanidine or of added choline in this system. These results differ from 
those obtained with foot-and-mouth disease virus in primary calf kidney 
cultures, where MEM caused some suppression of the inhibitory action of 
guanidine (Dinter and Bengtsson, 1964). It should be noted that this 
study did not utilize single cycle conditions of virus infection, and 
therefore small changes occurring in a single cycle of virus multiplica-
tion would be magnified over the course of several viral cycles. 
Inhibition of Poliovirus Multiplication by Guanidine in Different Cells 
To determine the effect of cell type on the inhibitory activity 
of guanidine, the following experiment was performed. HeLa cells, MKC 
and LLC-MK9 cells were inoculated with 100 PFU/cell of poliovirus. At 
1.5 hours after infection, guanidine at varying concentrations was added 
to pairs of cultures. All were harvested at 8 hours after infection. 
The results are shown in Figure 22. It is evident that guanidine at all 
concentrations used produced greater reductions of poliovirus yield in 
either of the monkey cell cultures than in HeLa cells. Viral replication 
in primary monkey kidney cells was reproducibly the most sensitive to 
guanidine. These results show that the degree of inhibition by guanidine 
at a given concentration is host cell dependent. 
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Table V 
Effect of Culture Medium on the 
Activities of Guanidine and Choline 
Treatment 
Virus yield, PFU/cell 
MEM ESG ESG/MEM 
Control 248 141 0.57 
0.3 mM guanidine' 0.17 0.11 0.65 
0.3 mM guanidine and 
1.0 mM choline 
62 33 0.53 
Added at 1.5 hours after infection. 
Cultures were incubated in reinforced Eagle's medium until infection 
and in MEM after infection. 
Cultures were incubated in ESG for 12 hours prior to infection as 
well as after infection. 
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Figure 22. Inhibition of poliovirus yield by guanidine in HeLa cells, 
LLC-MK9 cells and primary rhesus monkey kidney cells. Confluent mono-
layers of cells were infected at a multiplicity of 100 PFU/cell and 
treated with poliovirus antiserum as described in Materials and Methods. 
Guanidine was added at 1.5 hours after infection and all cultures were 
harvested at 8.0 hours after infection. Virus yields in untreated con-
trols were as follows: HeLa cells, 270 PFU/cell; LLC-MK2 cells, 290 
PFU/cell; MKC, 180 PFU/cell. 
76 
Blocking of Guanidine Action by Choline 
The ability of choline to block the inhibitory action of guanidine 
was examined in HeLa cells as a function of choline and guanidine concen-
trations. At 1.5 hours after infection guanidine and choline were added 
at several concentrations. Duplicate cultures were harvested at 8 hours 
after inoculation. Figure 23 shows that the inhibition caused by 0.3 or 
0.4 mM guanidine was blocked almost completely by the addition of 10.0 mM 
choline to the culture medium, and 0.1 mM choline was sufficient to cause 
considerable blocking. Furthermore, the very marked inhibition caused by 
guanidine at a concentration as high as 1.0 mM could be blocked partially 
by choline at high concentrations. The highest choline concentrations 
employed might be somewhat toxic to cells, although we observed no indi-
cations of such toxicity during the 6-8 hours of choline treatment. 
Treatment of infected cultures with concentrations of choline up to 50 
mM had no effect on the yield of poliovirus in the absence of guanidine. 
A similar experiment was carried out using all three cell types, 
but utilizing 0.4 mM guanidine in all cases. Figure 24 shows that when 
poliovirus replication was more strongly inhibited by guanidine in a 
given cell type, a higher concentration of choline was required to obtain 
an equivalent degree of blocking. Similar results were obtained at dif-
ferent guanidine concentrations. Host cell variation in sensitivity to 
the inhibitory action of guanidine appears to be the dominant factor in 
determining to what extent guanidine action may be blocked by a guanidine 
antagonist at a given concentration. 
Kinetics of Reversion of Guanidine Action by Choline 
Effect of Concentration of Choline. To determine the kinetics of 
poliovirus multiplication after reversion of guanidine inhibition by 
choline, infected HeLa cell monolayers were divided into two groups. 
One group received 1.6 ml MEM one hour after infection plus 0.2 ml each 
of the appropriate solutions to give final concentrations of 0.4 mM 
guanidine and either 10 or 0.1 mM choline. The other group received 1.6 
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Figure 23. Relationship between concentrations of choline and extent of 
blocking of the inhibitory effect of guanidine on poliovirus multiplica-
tion in HeLa cells. Input multiplicity was 160 PFU/cell. Guanidine and 
choline were added at 1.5 hours, and all cultures were harvested at 8.0 
hours after infection. The virus yield in untreated controls was 305 
PFU/cell. In the absence of added choline, 0.2 mM guanidine reduced 
virus yield to 60% of controls; 0.3 mM guanidine to 10%, and 0.4 mM 
guanidine to 0.57o of controls. One mM guanidine reduced the virus yield 
by at least 4 orders of magnitude, but residual input virus not neutral-
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Figure 24. Blocking of the inhibitory effect of guanidine on poliovirus 
multiplication by choline in HeLa cells, LLC-MK- cells and primary rhe-
sus monkey kidney cells. Input multiplicity was 100 PFU/cell. Guanidine 
(final concentration: 0.4 mM) and choline were added at 1.5 hours after 
infection. All cultures were harvested at 8.0 hours after infection. 
Virus yields in guanidine-treated cultures are expressed as percent of 
yields in untreated cultures of the same cell type, which were as follows: 
HeLa cells, 80 PFU/cell; LLC-MK2 cells, 147 PFU/cell; MKC, 124 PFU/cell. 
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harvested at various times after infection. Figure 25, part A, shows 
that after addition of 10 mM choline to guanidine-treated cultures, the 
viral growth kinetics were indistinguishable from those in control cul-
tures, except that the final virus yield was not quite as high as in 
controls. Figure 25, part B, shows that when 0.1 mM choline was added 
with guanidine, there was a delay before virus production was evident 
and the rate of production was less than that in controls. It cannot 
be determined from this experiment how long viral multiplication would 
continue under these conditions, but other experiments have indicated 
that after addition of small amounts of choline to guanidine-treated 
cultures, viral multiplication often continues for several hours after 
growth in control cultures has ceased. Thus, the 8-hour virus yields 
shown in Figures 23 and 24 may not represent the maximum yields of 
poliovirus in guanidine-treated cells in the presence of low concentra-
tions of choline. 
Effect of Time of Addition of Choline and Guanidine. The results 
of experiments in which the time of addition of choline was varied are 
shown in Figure 26. As noted above, when choline and guanidine were 
added simultaneously, the growth curve obtained was very similar to 
that in control cultures (Part A). Virus multiplication could first be 
detected at the same time as in control cultures, i.e. 2.5 hours after 
infection. In parts B and C, choline was added at thirty minutes and 
1.5 hours after guanidine, respectively, and in both cases the latent 
period was increased by the time during which guanidine, alone, was in 
the culture medium before the addition of choline. In all cases the 
rate of virus increase was similar to that in control cultures. These 
results indicate that choline can promptly and effectively reverse the 
action of guanidine. 
With this information available, experiments can be designed to 
determine whether the guanidine-sensitive process, i.e. the synthesis 
of viral RNA, is already in progress during the latter part of the 
latent period. Infected HeLa cell monolayers were divided into three 
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Figure 25. Kinetics of poliovirus multiplication in HeLa cells 
treated with guanidine and choline. Input multiplicity was 130 
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Figure 26. Relationship between time of addition of choline and 
kinetics of poliovirus multiplication in guanidine-treated HeLa 
cells. Input multiplicity was as follows: Part A: 130 PFU/cell; 
Part B: 85 PFU/cell; Part C: 110 PFU/cell. Guanidine was added 
at 1.5 hours after infection. In Part A choline was added at 1.5 
hours after infection; in Part B at 2 hours after infection, and 
in Part C at 3 hours after infection. 
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a control. The others received 1.6 ml MEM plus 0.2 ml each of the ap-
propriate solutions to give final concentrations of 0.4 mM guanidine 
and 10 mM choline. Figure 27A shows that when guanidine and choline 
were both added 1.5 hours after infection, choline permitted onset of 
virus multiplication with essentially normal kinetics without any 
lengthening of the latent period. However, when guanidine was added 
one hour after infection, followed by choline one-half hour later, there 
was a delay of one-half hour in the onset of multiplication. This 
clearly shows that the guanidine-sensitive process was already in 
progress between one and 1.5 hours after infection, which agrees with 
previous results obtained by a different technique (Eggers et al., 1965). 
Figure 27 demonstrates again that choline acts promptly and effectively. 
Effect of Cell Type. In the two monkey cell cultures, the kine-
tics of virus production were similar to those observed in HeLa cells 
during choline-mediated reversal of the guanidine block. Figure 28 
shows that in all three cell types when guanidine was added 1.5 hours 
after infection and choline at 3 hours after infection, the latent 
period was increased by 1.5 hours. Again, the rates of virus production 
were in all cases similar to those in untreated controls. In both 
LLC-MK~ cells and primary monkey kidney cells a final concentration of 
25 mM choline was used to insure maximum reversal of guanidine effect. 
These experiments again demonstrate the rapidity of choline action as 
well as the high degree of reversal of the guanidine effect that was 
possible when fairly high levels of choline were used. The somewhat 
lower virus yields obtained in cultures treated with both guanidine and 
choline, compared with those in untreated controls, probably indicate 
the inability of choline to reverse the action of guanidine at every 
site in the infected cell, a common finding in drug action. The simi-
larity of the kinetics of reversal in the three cell types suggests 
that the mechanism of choline reversal of guanidine action is similar 
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Figure 27. Time of onset of guanidine-sensitive process in poliovirus 
multiplication determined with the aid of choline. Input multiplicity 
was 180 PFU/cell. Guanidine was added at 1.5 hours after infection in 
Part A and at 1.0 hour after infection in Part B. Choline was added 
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Figure 28. Kinetics of poliovirus multiplication in HeLa cells, 
LLC-MK9 cells and primary cultures of rhesus monkey kidney cells 
after reversion of guanidine inhibition of poliovirus multipli-
cation. Input multiplicities were as follows: HeLa cells, 110 
PFU/cell; LLC-MK2 cells, 30 PFU/cell; MKC, 130 PFU/cell. Guani-
dine and choline were added at 1.5 and 3.0 hours, respectively; 
control cultures received PBS at 1.5 hours after infection. 
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Dimethylethanolamine (DME) as a Guanidine Antagonist 
Philipson et al. (1966) noted that, on a molar basis, DME was more 
active than choline in blocking the inhibitory activity of guanidine in 
poliovirus type 1-infected HeLa cells. We investigated the kinetics of 
poliovirus type 2 multiplication in HeLa cells treated simultaneously 
with 0.4 mM guanidine and either 0.1 mM choline or 0.1 mM DME. For com-
parison, the results obtained with 0.1 mM choline are shown again in 
Figure 29. Even though the virus multiplied,the rate of increase was 
slow. In contrast, almost complete blocking of guanidine action was 
achieved with 0.1 mM DME. The rates of virus production in control and 
guanidine plus DME-treated cultures were indistinguishable, but there 
was a short delay before the onset of multiplication. A somewhat 
shorter, but still detectable delay was observed when higher concentra-
tions of DME such as 10 mM were used. We have also observed a delay in 
onset of replication in poliovirus-infected LLC-MK- cells treated simul-
taneously with 0.4 mM guanidine and 0.1 mM DME. This might be due to a 
slower entry of DME into the cell or some preliminary biochemical trans-
formation required before DME can act. Philipson et al. (1966) noted 
that KB cells, a fibroblastic human cell line, are unable to utilize DME 
as effectively as choline in reversing the inhibitory action of guani-
dine. It is possible that different cell types possess varying capaci-
ties to make DME available in the form needed to reverse guanidine 
inhibition. 
Synergism Between Different Guanidine Antagonists 
Philipson et al. (1966) investigated the ability of DME to act 
synergistically with certain amino acids in blocking the poliovirus-
inhibitory activity of guanidine, and obtained evidence for such action. 
We have done similar experiments with choline and methionine. Figure 30 
demonstrates the synergistic action of choline and methionine in reversing 
the poliovirus-inhibitory activity of 1.0 mM guanidine in HeLa cells. 
However, we were unable to demonstrate synergism between choline and DME 
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Figure 29. Kinetics of poliovirus multiplication in HeLa cells after 
blocking the inhibitory effect of guanidine with choline or dimethyl-
ethanolamine (DME) at low concentrations. Input multiplicity was 130 
PFU/cell. At 1.5 hours after infection guanidine and choline or DME 
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Figure 30. Synergism between methionine and choline in blocking the 
virus-inhibitory action of guanidine in HeLa cells. Input multipli-
city was 65 PFU/cell. At 1.5 hours after infection, guanidine was 
added to a final concentration of 1.0 mM. At 2.0 hours after infec-
tion, choline and methionine were added to give the final concentra-
tions shown. In the mixtures of choline and methionine, these com-
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Figure 31. Lack of synergism between choline and dimethylethanolamine 
(DME) in blocking the virus-inhibitory action of guanidine in HeLa cells. 
Input multiplicity was 30 PFU/cell. At 1.5 hours after infection 
guanidine was added to a final concentration of 0.6 mM, and choline and 
DME were added to give the concentrations indicated. Where choline and 
DME were added to the same culture, the choline concentration was always 
0.1 mM, whereas DME concentration was 0.01, 0.05, or 0.1 mM. 
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Other experiments utilizing different concentrations of guanidine, 
choline and DME also failed to demonstrate a synergistic effect. Dinter 
and Bengtsson (1964) have shown that the most active guanidine antagonists 
among the amino acids in lactalbumin hydrolysate do not even show additive 
activity when used together. These results suggest that guanidine anta-
gonists may be separated.into several classes of compounds with similar 
structure on the basis of their lack of ability to act synergistically 
with each other. 
Action of Guanidine Antagonists in Blocking the Multiplication of 
Guanidine-dependent Poliovirus in the Presence of Guanidine 
If guanidine antagonists block the inhibitory action of guanidine 
on the guanidine-sensitive virus, then they should also suppress the pro-
moting effect of guanidine on a guanidine-dependent strain, unless guani-
dine acts at entirely different receptor sites in the two situations. 
Both Lwoff and Lwoff (1965) and Loddo et al. (1966) found that the 
poliovirus-supporting action of 0.2 to 0.4 mM guanidine could be blocked 
by guanidine antagonists. Philipson et al. (1966), using 1.0 mM guanidine 
and a series of guanidine antagonists, could not detect any effect on the 
multiplication of poliovirus type 1. However, even high concentrations 
of guanidine antagonists could not be expected to block measurably the 
action of 1.0 mM guanidine. We investigated the effect of several guani-
dine antagonists on the replication of guanidine-dependent poliovirus 
type 1 in HeLa cells in the presence of 0.4 mM guanidine. Our results, 
shown in Table VI, indicate that guanidine antagonists are very effective 
in blocking the promoting effect of guanidine on the growth of guanidine-
dependent mutants. 
Choline as an Antiguanidine - Possible Modes of Action 
Several hypotheses have been proposed for the mechanism of action 
of guanidine antagonists. Most of the compounds with known activity are 
capable of donating either a methyl or ethyl group, and therefore a 
methylation mechanism was considered by several investigators. Both 
Lwoff (1965) and Philipson and co-workers (1966) tested the hypothesis 
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Table VI 
Inhibition of Guanidine-dependent Poliovirus Type 1 
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Added at 1.5 hours after infection. 
Harvested at 8 hours after infection. 
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that choline or methionine inactivates guanidine by participating in its 
methylation. Methylguanidine is indeed very much less active in inhib-
iting poliovirus multiplication than is guanidine, but neither investi-
gator could obtain evidence for the production of methylguanidine in 
infected cells treated with guanidine and H-choline labeled in the 
methyl groups. Philipson and co-workers (1966) also reported that folic 
acid analogs, which inhibit dihydrofolate reductase, an enzyme used in 
de novo synthesis of methyl groups, had no effect on the blocking of 
guanidine action. Loddo and co-workers (1966) noted that some of the 
active antiguanidine compounds, such as trimethylamine, are not known 
to be methyl donors. At the same time, betaine, a very active methyl 
donor, is completely inactive as a guanidine antagonist. They therefore 
concluded that, if methylation or ethylation was involved in the block-
ing of guanidine inhibition, it must not involve a known biological 
me thylating system. 
Another hypothesis for the mechanism of action of choline is that 
it promotes the exit of guanidine from the cell. To test this hypothesis 
the following experiment was performed. HeLa cells were grown in mono-
layers in 60 mm tissue culture dishes containing 3 coverslips each. 
14 
Cells were incubated for 4 hours in the presence of 0.01 mM C-guanidine, 
0.8 uCi/p.late, washed twice with warm PBS, and 2.0 ml MEM or MEM contain-
ing either 10 mM choline or 1.0 mM unlabeled guanidine was added. After 
incubating for various lengths of time, the coverslips were harvested by 
dipping in a beaker containing warm PBS, drained by touching one edge to 
a paper towel and dried in coverslip racks. The radioactivity was deter-
mined by counting in glass scintillation vials in toluene-Liquifluor 
scintillator as described in Materials and Methods. As shown in Figure 32, 
after removal of labeled guanidine from the culture fluids, cells incubated 
in unlabeled guanidine lost their labeled guanidine somewhat faster than 
cells incubated in MEM alone, but cells incubated in choline retained the 
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Figure 32. Rate of exit of C-guanidine from HeLa cells incubated with 
14 
or without choline. Each determination represents the mean of C 
radioactivity from 6 coverslips. Prewash values were determined by 
removing coverslips from tissue culture dishes still containing 
14 
C-guanidine after 4.0 hours of incubation. They were dipped in warm 
PBS, drained and dried in the same manner as experimental coverslips. 
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Discussion 
The results presented in this chapter indicate that there are sig-
nificant differences in the sensitivity of poliovirus biosynthesis to 
inhibition by guanidine in various cell types. Of the three cell types 
examined, sensitivity increases in the order: HeLa cells, LLC-MK. cells, 
and primary rhesus monkey kidney cells. More choline is required to pro-
duce an equivalent degree of blocking or reversal in cells more strongly 
inhibited by guanidine. 
Kinetic experiments with all three cell types show that choline at 
high concentrations is capable of blocking the action of simultaneously 
added 0.4 mM guanidine without measurable delay. The rate of virus mul-
tiplication in such cultures is indistinguishable from that in control 
cultures which had received neither guanidine nor choline. 
When choline is added after guanidine, measurable virus production 
begins after a delay that depends on the time in the growth cycle when 
guanidine was added and on the kinetics of virus multiplication in a 
particular cell type. These two factors determine the extent to which 
virus biosynthetic events have progressed before guanidine addition halts 
viral RNA synthesis. When choline is added to such cultures, the delay 
observed is that which would be expected if choline released the guanidine 
inhibition immediately. The kinetics of virus multiplication after 
choline treatment of guanidine-inhibited cultures correspond closely to 
the time course of virus increase observed after washing guanidine out 
of cells (Eggers et al., 1965). The rapidity of the antiguanidine action 
of choline is striking and places restraints on any hypothesis on its 
mode of action. 
The activity of choline cannot be explained by the hypothesis that 
it promotes the exit of guanidine from the cell, since experiments on the 
14 
rate of exit of C-guanidine from HeLa cells have shown that choline 
actually delays somewhat the exit of guanidine from cells. Choline could 
prolong the cellular retention of guanidine in several ways by acting 
either at the plasma membrane or intracellularly, but we have no informa-
tion on the mechanism involved. 
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Our experiments with guanidine-dependent poliovirus indicate that 
guanidine antagonists block the poliovirus-supporting activity of guani-
dine, as well as its inhibitory activity. This confirms earlier studies 
by Lwoff and Lwoff (1965) and by Loddo et al. (1966). The fact that 
Philipson et al. (1966) could not demonstrate an effect of guanidine 
antagonists on the multiplication of guanidine-dependent poliovirus in 
the presence of 1.0 mM guanidine may be explained by the relatively high 
concentration of guanidine used. 
Results of experiments utilizing pairs of antiguanidine compounds 
simultaneously suggest that these compounds fall into several classes. 
Amino acids apparently form one such class on the basis that they are 
incapable of synergistic action with one another (Dinter and Bengtsson, 
1964), but can act synergistically with choline or DME (Philipson et al., 
1966; see Figure 30). Our experiments indicate that choline and DME, 
which are closely related structurally, may be members of another class, 
since they also are incapable of synergistic action with each other. 
Taken together, these observations suggest that amino acids and compounds 
structurally related to choline act at different sites in reversing 
guanidine action. 
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The studies described in this dissertation were undertaken in an 
effort to further the understanding of the biochemistry of poliovirus 
replication. We have demonstrated a progressive increase in the smooth 
membranes with which viral RNA synthesis is associated; these membranes 
probably correspond to the rapidly proliferating smooth membrane-bounded 
cisternae seen by electron microscopy of infected cells. The accumula-
tion continues at late times after infection, when cellular nucleic acid 
and protein syntheses have declined markedly, and viral RNA synthesis 
has also declined. Viral protein products have accumulated by this time. 
Guanidine, which stops viral RNA synthesis, has been shown by Dales and 
co-workers (1965) to prevent the proliferation of the small cisternae; 
we have shown that guanidine prevents the great increase in membranes 
in Fraction 2. Yet under these same conditions of infection, guanidine 
does not abolish the increased incorporation of choline into cellular 
membranes. Thus, although increased incorporation of precursors into 
membranes, and the accumulation of smooth microsomal membranes are un-
doubtedly associated in the normal course of poliovirus infection, they 
are not inseparably linked to each other. 
Production of Cellular Membranes 
Membrane components have been shown to be synthesized and inserted 
into membranes at independent rates. In rats, microsomal membrane syn-
thesis accelerates in the fetal liver at the end of gestation, while 
microsomal enzyme activities are increased later, in the early postnatal 
period (Dallner et al., 1965a,b). The rates of increase in activities 
of different enzymes also vary (Dallner et al., 1966b). The turnover 
rates of membrane lipids and proteins in young rats have been found to 
differ. Different rates have been found for fatty acids and for the 
glycerol backbone of phospholipids, and for two different enzymes (Omura 
et al., 1967). These data are consistent with the hypothesis of Dallner, 
Siekevitz and Palade (Dallner et al., 1966b) that membranes are 
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synthesized in a multistep assembly process. They are dynamic structures, 
constantly being renewed and modified to fit the cell's needs. 
This implies independent control mechanisms for the production of 
membrane constituents. There is evidence that in some bacteria the con-
trol processes are not tightly coupled. In Bacillus subtilis mutants 
which require glycerol for the synthesis of phospholipids, proteins may 
be synthesized and incorporated into the membranes of the bacteria at 
nearly normal rates without net synthesis of phospholipids. This leads 
to a diminution of the phospholipid/protein ratio and an increase in the 
buoyant density of the membranes (Mindich, 1970a,b) . It was also shown 
that cells treated with chloramphenicol and supplied with exogenous 
glycerol produced membranes with a lipid content 15-30% higher than 
membranes from untreated cells. However, in this case, the incorporation 
of labeled glycerol into membranes stopped within an hour after adminis-
tration of chloramphenicol, suggesting that some protein synthesis is 
necessary for continued synthesis of lipids. There is suggestive evi-
dence that this may also be true in mammals. Tzur and Shapiro (1964) 
found that in isolated microsomal preparations from rat liver, synthesis 
14 
of lipids from L-a-glycerophosphate-1-C was greatly stimulated by addi-
tion of protein or glycoprotein to the incubation mixture. They postu-
lated that lipid synthesis might be limited by the amount of acceptor 
protein available. Schiefer (1969) demonstrated inhibition of incorpor-
ation of choline into rat liver membranes after administration of 
cycloheximide to the intact animal. 
Synthesis of Membrane Components in Picornavirus-infected Cells 
The synthesis and incorporation of membrane phospholipids are 
accelerated in picornavirus-infected cells at a time when cellular protein 
synthesis is greatly diminished. In fact, L cells which have been in-
fected with the large plaque variant of mengovirus continue to incorporate 
labeled choline into membranes at an enhanced rate compared to uninfected 
cells at a time when 60 to 80% of the cells are undergoing cytopathic 
degeneration as measured by staining with 0.05% erythrocin (Amako and 
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Dales, 1967a,b). Thus, picornavirus-infected cells provide another 
example of independent control of the synthesis of membrane constituents. 
A virus product apparently triggers the synthesis of membrane phospho-
lipids, and many of these become components of the smooth-walled vesicles 
with which viral RNA synthesis is associated. Not all of the components 
of the smooth membranes in infected cells are, however, newly synthesized. 
Their phospholipids derive both from preexisting and newly synthesized 
molecules (Amako and Dales, 1967b). There is probably a preexisting pool 
of cellular membrane proteins which are incorporated into membranes after 
picornavirus infection, since synthesis of new proteins from cellular 
messenger RNA is greatly reduced. That the smooth membranes of Fraction 
2 contain cellular proteins has been demonstrated. If cells are labeled 
3 
with H-amino acids prior to infection, label sediments with the membranes 
of this fraction, and polyacrylamide gel electrophoresis reveals many 
peptide peaks (Caliguiri, unpublished observations). 
There is evidence, however, that most of the smooth membranes in 
Fraction 2 of infected cells represent a structure found in significant 
quantities only in infected cells. Very little membranous material from 
uninfected cells is found at the density of these smooth membranes and 
the phospholipid/protein ratio is lower than that of the equivalent 
fraction from infected cells. The phospholipid content of membranes in 
Fraction 2 of infected and uninfected cells differs (See Table II, 
Chapter 3). Some viral proteins are associated with these membranes of 
infected cells. When actinomycin D-treated cells are labeled for 1.5 
35 3 
hours with S-methionine or H-amino acids after infection, only a 
small percentage of the incorporated label sediments in this fraction, 
but the label which is found here is quite firmly bound. A significant 
amount of label remains with the membranes when they are pelleted and 
recentrifuged in a continuous sucrose gradient (Caliguiri and Mosser, 
submitted for publication). The major labeled proteins in this fraction 
migrate with the major capsid proteins of poliovirus in polyacrylamide 
gels. The precursor protein (VPO) which is cleaved to form VP2 and VP4 
is also found in this fraction as are some larger proteins which probably 
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represent other primary and secondary products of poliovirus protein 
synthesis. The electrophoresis pattern of protein is consistent with 
the hypothesis that all newly labeled proteins are viral in origin. 
Finally, there is associated with the smooth membranes from Fraction 2 
of infected cells a new enzyme activity, the viral RNA polymerase. 
Our results are compatible with the hypothesis that membrane 
components are synthesized and assembled in the rough endoplasmic 
reticulum, and that the components of the smooth endoplasmic reticulum 
are derived from rough surfaced membranes (Dallner et al., 1965a,b; 1966a; 
Orrenius, 1965; Orrenius and Erickson, 1966). We have found that very 
3 
short pulses of H-choline (e.g. 3 minutes) label predominantly the 
pellicle fraction whose major constituent is rough microsomes. After 
longer periods of labeling, such as 30 minutes, a substantial amount of 
radioactivity is found in the smooth membrane fraction of infected cells 
which contains proliferating cisternae. 
3 
Pulse-chase studies with glycerol-2- H have confirmed that radio-
activity incorporated into the rough endoplasmic reticulum can be chased 
into the smooth membranes in infected cells, suggesting a precursor-
product relationship. 
Three hypotheses may be considered to explain the increased in-
3 
corporation of H-choline into phospholipids after picornavirus infection: 
(1) a decrease in the size of the intracellular pool of choline in 
soluble form, (2) an increased rate of turnover without change in net 
phospholipid synthesis, and (3) an increased rate of synthesis without 
a concomitant increase in the rate of breakdown. 
Pool size changes have not been ruled out, but we consider such 
changes unlikely to explain all the results. In considering hypotheses 
2 and 3, the available results suggest that the rate of phospholipid 
synthesis must exceed the rate of degradation, since the phospholipid 
content of infected cells (Amako and Dales, 1967b) and the phospholipid/ 
protein ratio of infected cells (See Chapter 3, Table I, totals) 
increase as a result of infection. If the last hypothesis is true, 
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then infected cells either utilize preexisting cellular proteins and/or 
viral proteins for formation of membranes, or they make relatively lipid-
rich membranes. There is evidence that the last alternative is correct 
to some extent. The phospholipid/protein ratio of the total of the 
fractions from infected cells increases with time after infection. Most 
likely, the proteins from preexisting cellular pools are also being 
inserted into these membranes but the rate is lower than the rate of 
insertion of phospholipids. 
Blocking of Guanidine Action by Choline 
There is good evidence that exogenous choline is utilized rapidly 
and efficiently by cells in making membranes (Plagemann, 1968). Infected 
cells incorporate labeled choline at an even faster rate for the same 
purpose. Since most of the guanidine blockers could also be used in the 
synthesis of membranes, do they block guanidine action in this way? For 
a variety of reasons we consider that this is probably not the mode of 
action of these compounds. 
First, the inhibitory action of guanidine can be blocked extremely 
rapidly. Choline blocks or reverses guanidine inhibition without a 
measurable delay. The kinetics of virus multiplication after reversal of 
guanidine inhibition with dimethylethanolamine show a slight but signifi-
cant delay. This may indicate that some sort of biochemical change must 
be made in the molecule before it is active or that dimethylethanolamine 
enters the cell more slowly than choline, but it does not necessarily 
point towards incorporation in a cellular structure. 
Second, guanidine blockers, which enable the replication of drug-
sensitive virus in the presence of guanidine, prevent the replication of 
drug-dependent virus under such conditions. This result is not compati-
ble with a view that the blockers act by promoting synthesis of cellular 
membranes essential for poliovirus multiplication. 
Finally, if we concentrate on choline, there are some apparent 
paradoxes in the concentrations we find to be active in blocking the 
inhibitory action of guanidine, and quantities known to be present in 
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the cell or taken up from the medium. Almost all intracellular choline 
is found in two locations; in a soluble pool which does not exchange 
readily with the extracellular medium (Amako and Dales, 1967b; Plagemann, 
1968), or incorporated into cellular membranes. Plagemann (1968) found 
that almost all of the soluble choline pool in Novikoff rat hepatoma cells 
was in the form of phosphorylcholine. This is an intermediate in the 
formation of phosphatidylcholine, which is incorporated into membranes 
(Kennedy, 1957). We estimate from preliminary data that the total con-
centration of choline in all acid-soluble forms is probably on the order 
of 1.0 mM or higher. It is noteworthy that 1.0 mM choline, added to 
poliovirus-infected cells treated with 0.4 mM guanidine is capable of 
reversing to a large extent the inhibitory effect of guanidine (See 
Chapter 5, Figure 24). This suggests that added choline is needed in an 
intracellular state different from that of choline which makes up the 
bulk of the soluble pool. It is possible that choline is needed in an 
unphosphorylated state. 
The problem of choline activity is further complicated by the 
fact that, in uninfected Novikoff rat hepatoma cells (Plagemann, 1968) 
or L cells (Amako and Dales, 1967b) a concentration of 0.01 to 0.06 mM 
choline is saturating for uptake into the cells over a period of one hour. 
The concentrations required for marked blocking of guanidine action 
generally exceed this level, yet choline added at adequate concentrations 
is active within a very short time interval. It is possible that choline 
uptake varies widely with the cell strain used and is faster in all three 
cell types used in our studies, but this is unlikely. Or, perhaps at 
very high choline concentrations a large amount of choline enters cells 
by simple diffusion. 
If choline blocked the inhibitory activity of guanidine by partici-
pating in the synthesis of new membranes, we might expect to see a further 
increase in choline incorporation after treatment of infected cells with 
guanidine. This has not been observed in the present experiments (See 
Chapter 4). 
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The possibilities that the action of guanidine is blocked via a 
methylation or ethylation reaction, or that choline ejects guanidine from 
the cell were discussed earlier (Chapter 5), and are considered unlikely. 
The available evidence is more in accord with the possibility that 
both guanidine and guanidine antagonists act by binding to a viral or 
cellular component which is important in viral RNA replication. This 
might be the viral polymerase or some cellular cofactor or membrane site 
necessary for its proper functioning. The interactions of these compounds 
with viral or cellular components have the characteristics of weak bonds. 
Guanidine is very difficult to localize within the cell. It can be washed 
out of cells effectively merely by changing the medium bathing the cells. 
We have attempted to demonstrate the binding of labeled guanidine to viral 
or cellular components by equilibrium dialysis without success. Since it 
is a charged molecule, it is likely that guanidine forms transient associ-
ations at many intracellular sites, and perhaps only a few of these sites 
are involved in poliovirus RNA synthesis. 
It is tempting to speculate that guanidine affects poliovirus RNA 
synthesis by binding to the smooth membranes with which this process is 
associated. The differing sensitivities to guanidine in different cell 
types indicate that a cellular component is involved in some way, and we 
can easily envision the positively charged guanidine molecules interacting 
with the negatively charged membrane phospholipids. There is evidence 
that another strongly negatively charged molecule involved in viral RNA 
synthesis, the viral nucleic acid, is not the site with which guanidine 
interacts. The genome of a guanidine-sensitive virus may be replicated 
and therefore rescued from cells by the RNA polymerase of a guanidine-
resistant mutant (Agol and Shirman, 1964; Cords and Holland, 1964; 
Ikegami et al., 1964; Wecker and Lederhilger, 1964). 
Choline and related compounds could block or reverse the action of 
guanidine by similar associations with a receptor site or sites. Molecular 
dissimilarity between choline-like guanidine antagonists and guanidine 
make it improbable that the antagonists and guanidine have identical 
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receptor sites. Also, the phenomenon of synergism between classes of 
guanidine antagonists leads us to postulate separate sites for the action 
of different groups of guanidine antagonists. We speculate that the 
binding of a guanidine antagonist at particular intracellular receptors 
contiguous to the critical guanidine binding sites alters the micro-
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